{"messages":[{"status":"ok","cursor":"480","count":30,"total":9467}], "collection":[{"rel_doi":"10.1101\/2020.09.21.20198416","rel_title":"Estimate of the actual number of COVID-19 cases from the analysis of deaths.","rel_date":"2020-09-23","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.09.21.20198416","rel_abs":"Using the calculated values for the Infection Fatality Rate (IFR) of COVID-19 it is possible to estimate the prevalence of cases of infection in the city of Buenos Aires, Argentina, throughout the pandemic. The use of confirmed cases as a metric and their replacement by more reliable parameters such as death figures are discussed. The results are analyzed according to age ranges and possible sources of error in the estimates are established.","rel_num_authors":2,"rel_authors":[{"author_name":"Roberto Etchenique","author_inst":"FCEyN - UBA - CONICET"},{"author_name":"Rodrigo Quiroga","author_inst":"FCQ - UNC - CONICET"}],"version":"1","license":"cc_by_nc_nd","type":"PUBLISHAHEADOFPRINT","category":"epidemiology"},{"rel_doi":"10.1101\/2020.09.23.20199927","rel_title":"Challenges and opportunities of the COVID-19 pandemic for perinatal mental health care: a mixed methods study of mental health care staff","rel_date":"2020-09-23","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.09.23.20199927","rel_abs":"Purpose: the aim of this study was to explore staff perceptions of the impact of the COVID-19 pandemic on mental health service delivery and outcomes for women who were pregnant or in the first year after birth (perinatal women). Methods: secondary analysis of an online mixed-methods survey open to all mental health care staff in the UK involving 363 staff working with women in the perinatal period. Results: staff perceived the mental health of perinatal women to be particularly vulnerable to the impact of stressors associated with the pandemic such as social isolation (rated by 79.3% as relevant or extremely relevant; 288\/363) and domestic violence and abuse (53.3%; 192\/360). As a result of changes to mental health and other health and social care services, staff reported feeling less able to assess women, particularly their relationship with their baby (43.3%; 90\/208), and to mobilise safeguarding procedures (29.4%; 62\/211). While 42% of staff reported that some women engaged poorly with virtual appointments, they also found flexible remote consulting to be beneficial for some women and helped time management due to reductions in travel time. Conclusions: delivery of perinatal care needs to be tailored to the needs of women; virtual appointments are perceived not to be appropriate for assessments but may be helpful for some women in subsequent interactions. Safeguarding and other risk assessment procedures must remain robust in spite of modifications made to service delivery during pandemics.","rel_num_authors":6,"rel_authors":[{"author_name":"Claire A Wilson","author_inst":"King's College London"},{"author_name":"Christian A Dalton-Locke","author_inst":"University College London"},{"author_name":"Sonia Johnson","author_inst":"University College London"},{"author_name":"Alan Simpson","author_inst":"King's College London"},{"author_name":"Sian Oram","author_inst":"King's College London"},{"author_name":"Louise M Howard","author_inst":"King's College London"}],"version":"1","license":"cc_by","type":"PUBLISHAHEADOFPRINT","category":"psychiatry and clinical psychology"},{"rel_doi":"10.1101\/2020.09.22.20199455","rel_title":"Norwich COVID-19 Testing Initiative: feasibility project evaluation","rel_date":"2020-09-23","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.09.22.20199455","rel_abs":"Background There is a high prevalence of COVID-19 in university-age students, who are returning to campuses. There is little evidence regarding the feasibility of universal, asymptomatic testing to help control outbreaks in this population. This study aimed to pilot mass COVID-19 testing on a university research park, to assess the feasibility and acceptability of scaling up testing to all staff and students. Methods This was a cross-sectional feasibility study on a university research park in the East of England. All staff and students (5,625) were eligible to participate. All participants were offered 4 PCR swabs, which they self-administered over two weeks. Outcome measures included: uptake; drop-out rate; positivity rates; participant acceptability measures; laboratory processing measures; data collection and management measures. Results 798 (76%) of 1053 who registered provided at least one swab. 687 (86%) provided all four. 792 (99%) of 798 who submitted at least one swab had all negative results. 6 participants had one inconclusive result. There were no positive results. 458 (57%) of 798 participants responded to a post-testing survey, demonstrating a mean acceptability score of 4.51\/5, with 5 being the most positive. Conclusions Repeated self-testing for COVID-19 using PCR is feasible and acceptable to a university population.","rel_num_authors":25,"rel_authors":[{"author_name":"Tara Berger Gillam","author_inst":"University of East Anglia"},{"author_name":"Jennifer Cole","author_inst":"University of East Anglia"},{"author_name":"Karim Gharbi","author_inst":"Earlham Institute"},{"author_name":"Emily Angiolini","author_inst":"Earlham Institute"},{"author_name":"Tom O Barker","author_inst":"Earlham Institute"},{"author_name":"Peter Bickerton","author_inst":"Earlham Institute"},{"author_name":"Thomas Brabbs","author_inst":"Earlham Institute"},{"author_name":"Jeannette S Chin","author_inst":"University of East Anglia"},{"author_name":"Enrico Coen","author_inst":"John Innes Centre"},{"author_name":"Sarah Cossey","author_inst":"Earlham Institute"},{"author_name":"Robert P Davey","author_inst":"Earlham Institute"},{"author_name":"Rose Davidson","author_inst":"University of East Anglia"},{"author_name":"Alex Durrant","author_inst":"Earlham Institute"},{"author_name":"Dylan Edwards","author_inst":"University of East Anglia"},{"author_name":"Neil Hall","author_inst":"Earlham Institute"},{"author_name":"Suzanne Henderson","author_inst":"Earlham Institute"},{"author_name":"Mark Hitchcock","author_inst":"UEA Health and Social Care Partners"},{"author_name":"Naomi Irish","author_inst":"Earlham Institute"},{"author_name":"James Lipscombe","author_inst":"Earlham Institute"},{"author_name":"Greg Jones","author_inst":"Earlham Institute"},{"author_name":"Gerard Parr","author_inst":"University of East Anglia"},{"author_name":"Stuart A Rushworth","author_inst":"University of East Anglia"},{"author_name":"Neil Shearer","author_inst":"Earlham Institute"},{"author_name":"Russell Smith","author_inst":"University of East Anglia"},{"author_name":"Nick Steel","author_inst":"University of East Anglia"}],"version":"1","license":"cc_by_nc_nd","type":"PUBLISHAHEADOFPRINT","category":"public and global health"},{"rel_doi":"10.1101\/2020.09.21.20198309","rel_title":"Early Humoral Response Correlates with Disease Severity and Outcomes in COVID-19 Patients","rel_date":"2020-09-23","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.09.21.20198309","rel_abs":"The Coronavirus Disease 2019 (COVID-19), caused by the novel SARS-CoV-2, continues to spread globally with significantly high morbidity and mortality rates. Immunological surrogate markers, in particular antigen-specific responses, are of unquestionable value for clinical management of patients with COVID-19. Here, we investigated the kinetics of IgM, IgG against the spike (S) and nucleoproteins (N) proteins and their neutralizing capabilities in hospitalized patients with RT-PCR confirmed COVID-19 infection. Our data show that SARS-CoV-2 specific IgG, IgM and neutralizing antibodies (nAbs) were readily detectable in almost all COVID-19 patients with various clinical presentations. Notably, anti-S and -N IgG, peaked 20-40 day after disease onset, and were still detectable for at least up to 70 days, with nAbs observed during the same time period. Moreover, nAbs titers were strongly correlated with IgG antibodies. Significantly higher levels of nAbs as well as anti-S1 and N IgG and IgM antibodies were found in patients with more severe clinical presentations, patients requiring admission to intensive care units (ICU) or those with fatal outcomes. Interestingly, lower levels of antibodies, particularly anti-N IgG and IgM in the first 15 days after symptoms onset, were found in survivors and those with mild clinical presentations. Collectively, these findings provide new insights into the characteristics and kinetics of antibody responses in COVID-19 patients with different disease severity.","rel_num_authors":25,"rel_authors":[{"author_name":"Anwar M Hashem","author_inst":"King Abdulaziz University"},{"author_name":"Abdullah Algaissi","author_inst":"Jazan University"},{"author_name":"Sarah A Almahboub","author_inst":"King Abdulaziz University"},{"author_name":"Mohamed A Alfaleh","author_inst":"King Abdulaziz University"},{"author_name":"Turki S Abujamel","author_inst":"King Abdulaziz University"},{"author_name":"Sawsan S Alamri","author_inst":"King Abdulaziz University"},{"author_name":"Khalid A Alluhaybi","author_inst":"King Abdulaziz University"},{"author_name":"Haya I Hobani","author_inst":"King Abdulaziz University"},{"author_name":"Rahaf H AlHarbi","author_inst":"King Abdulaziz University"},{"author_name":"Reem M Alsulaiman","author_inst":"King Abdulaziz University"},{"author_name":"M-Zaki ElAssouli","author_inst":"King Abdulaziz University"},{"author_name":"Sharif Hala","author_inst":"King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, Ministry of National Guard Health Affairs, Jeddah, "},{"author_name":"Naif K Alharbi","author_inst":"King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, Ministry of National Guard Health Affairs, Riyadh, "},{"author_name":"Rowa Y Alhabbab","author_inst":"King Abdulaziz University"},{"author_name":"Ahdab A AlSaieedi","author_inst":"King Abdulaziz University"},{"author_name":"Wesam H Abdulaal","author_inst":"King Abdulaziz University"},{"author_name":"Abdullah Bukhari","author_inst":"Imam Mohammed Ibn Saud Islamic University, Riyadh, Saudi Arabia"},{"author_name":"Afrah A AL-Somali","author_inst":"Infectious Diseases Department, King Abdullah medical complex, Jeddah, Saudi Arabia"},{"author_name":"Fadwa S Alofi","author_inst":"Infectious Diseases Department, King Fahad Hospital, Almadinah Almunwarah, Saudi Arabia"},{"author_name":"Asim A Khogeer","author_inst":"Plan and Research Department, General Directorate of Health Affairs Makkah Region, Ministry of Health, Makkah, Saudi Arabia"},{"author_name":"Arnab Pain","author_inst":"King Abdullah University for Science and Technology"},{"author_name":"Almohanad A Alkayyal","author_inst":"University of Tabuk, Tabuk, Saudi Arabi"},{"author_name":"Naif AM Almontashiri","author_inst":"Taibah University, Almadinah Almunwarah, Saudi Arabia"},{"author_name":"Ahmad B Mahmoud","author_inst":"Taibah University, Saudi Arabia"},{"author_name":"Xuguang Li","author_inst":"Centre for Biologics Evaluation, Biologics and Genetic Therapies Directorate, Health Products and Food Branch (HPFB), Health Canada and WHO Collaborating Center"}],"version":"1","license":"cc_by_nc_nd","type":"PUBLISHAHEADOFPRINT","category":"infectious diseases"},{"rel_doi":"10.1101\/2020.09.21.20199109","rel_title":"Nature and dimensions of the cytokine storm and its attenuation by convalescent plasma in severe COVID-19","rel_date":"2020-09-23","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.09.21.20199109","rel_abs":"In a randomized control trial on convalescent plasma therapy (CPT) in severe COVID-19, we characterized the nature, in terms of abundance of forty eight cytokines, and dimensions, in terms of their interrelationships, of the hyper-immune activation-associated cytokine storm in patients suffering from acute respiratory distress syndrome. We found plasma MCP3 level to be a key correlate for mitigation of hypoxia, irrespective of therapeutic regimen. We also identified an anti-inflammatory role of CPT independent of its neutralizing antibody content, and a linear regression analysis revealed that neutralizing antibodies as well as the anti-inflammatory effect of CPT both contribute to marked immediate reductions in hypoxia, as compared to patients on standard therapy.","rel_num_authors":25,"rel_authors":[{"author_name":"Purbita Bandopadhyay","author_inst":"CSIR-Indian Institute of Chemical Biology"},{"author_name":"Ranit D'Rozario","author_inst":"CSIR-Indian Institute of Chemical Biology"},{"author_name":"Abhishake Lahiri","author_inst":"CSIR-Indian Institute of Chemical Biology"},{"author_name":"Jafar Sarif","author_inst":"CSIR-Indian Institute of Chemical Biology"},{"author_name":"Yogiraj Ray","author_inst":"ID & BG Hospital"},{"author_name":"Shekhar Ranjan Paul","author_inst":"ID & BG Hospital"},{"author_name":"Rammohan Roy","author_inst":"ID & BG Hospital"},{"author_name":"Rajsekhar Maiti","author_inst":"ID & BG Hospital"},{"author_name":"Kausik Chaudhuri","author_inst":"ID & BG Hospital"},{"author_name":"Sougata Bagchi","author_inst":"ID & BG Hospital"},{"author_name":"Ayan Maiti","author_inst":"ID & BG Hospital"},{"author_name":"Md. Masoom Parwez","author_inst":"ID & BG Hospital"},{"author_name":"Biswanath Sharma Sarkar","author_inst":"ID & BG Hospital"},{"author_name":"Devlina Roy","author_inst":"ID & BG Hospital"},{"author_name":"Rahul Chakraborty","author_inst":"ID & BG Hospital"},{"author_name":"Janani Srinivasa Vasudevan","author_inst":"CSIR-Institute of Genomics & Integrative Biology"},{"author_name":"Sachin Sharma","author_inst":"CSIR-Institute of Genomics & Integrative Biology"},{"author_name":"Durba Biswas","author_inst":"Medical College Hospital"},{"author_name":"Chikam Maiti","author_inst":"Medical College Hospital"},{"author_name":"Bibhuti Saha","author_inst":"School of Tropical Medicine"},{"author_name":"Prasun Bhattacharya","author_inst":"Medical College Hospital"},{"author_name":"Rajesh Pandey","author_inst":"CSIR-Institute of Genomics & Integrative Biology"},{"author_name":"Shilpak Chatterjee","author_inst":"CSIR-Indian Institute of Chemical Biology"},{"author_name":"Sandip Paul","author_inst":"CSIR-Indian Institute of Chemical Biology"},{"author_name":"Dipyaman Ganguly","author_inst":"CSIR-Indian Institute of Chemical Biology"}],"version":"1","license":"cc_no","type":"PUBLISHAHEADOFPRINT","category":"infectious diseases"},{"rel_doi":"10.1101\/2020.09.20.20198192","rel_title":"Panbio antigen rapid test is reliable to diagnose SARS-CoV-2 infection in the first 7 days after the onset of symptoms","rel_date":"2020-09-23","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.09.20.20198192","rel_abs":"Background: Real-time reverse transcription polymerase chain reaction (RT-qPCR) is the current recommended laboratory method to diagnose SARS-CoV-2 acute infection, several factors such as requirement of special equipment, time consuming, high cost and skilled staff limit the use of these time-consuming molecular techniques. A more rapid and high-throughput method is in growing demand Methods: Evaluate the performances of the Panbio COVID-19 AG Rapid Test Device (Nasopharyngeal), a rapid immunochromatographic test for the detection of SARS-CoV-2 antigen, in comparison to RT-qPCR. Results: The RDT evaluated in this study showed a high sensitivity and specificity in samples mainly obtained during the first week of symptoms and with high viral loads. Conclusions: This assay seems to be an effective strategy for controlling the COVID-19 pandemic for the rapid identification and isolation of SARS-CoV-2 infected patients.","rel_num_authors":7,"rel_authors":[{"author_name":"Manuel Linares","author_inst":"Hospital Universitario Principe de Asturias"},{"author_name":"Ram\u00f3n P\u00e9rez Tanoira","author_inst":"Hospital Universitario Pr\u00edncipe de Asturias"},{"author_name":"Juan Romanyk","author_inst":"Hospital Universitario Pr\u00edncipe de Asturias"},{"author_name":"Felipe P\u00e9rez Garc\u00eda","author_inst":"Hospital Universitario Pr\u00edncipe de Asturias"},{"author_name":"Pe\u00f1a G\u00f3mez-Herruz","author_inst":"Hospital Universitario Pr\u00edncipe de Asturias"},{"author_name":"Teresa Arroyo","author_inst":"Hospital Universitario Pr\u00edncipe de Asturias"},{"author_name":"Juan Cuadros","author_inst":"Hospital Universitario Pr\u00edncipe de Asturias"},{"author_name":"Rajsekhar Maiti","author_inst":"ID & BG Hospital"},{"author_name":"Kausik Chaudhuri","author_inst":"ID & BG Hospital"},{"author_name":"Sougata Bagchi","author_inst":"ID & BG Hospital"},{"author_name":"Ayan Maiti","author_inst":"ID & BG Hospital"},{"author_name":"Md. Masoom Parwez","author_inst":"ID & BG Hospital"},{"author_name":"Biswanath Sharma Sarkar","author_inst":"ID & BG Hospital"},{"author_name":"Devlina Roy","author_inst":"ID & BG Hospital"},{"author_name":"Rahul Chakraborty","author_inst":"ID & BG Hospital"},{"author_name":"Janani Srinivasa Vasudevan","author_inst":"CSIR-Institute of Genomics & Integrative Biology"},{"author_name":"Sachin Sharma","author_inst":"CSIR-Institute of Genomics & Integrative Biology"},{"author_name":"Durba Biswas","author_inst":"Medical College Hospital"},{"author_name":"Chikam Maiti","author_inst":"Medical College Hospital"},{"author_name":"Bibhuti Saha","author_inst":"School of Tropical Medicine"},{"author_name":"Prasun Bhattacharya","author_inst":"Medical College Hospital"},{"author_name":"Rajesh Pandey","author_inst":"CSIR-Institute of Genomics & Integrative Biology"},{"author_name":"Shilpak Chatterjee","author_inst":"CSIR-Indian Institute of Chemical Biology"},{"author_name":"Sandip Paul","author_inst":"CSIR-Indian Institute of Chemical Biology"},{"author_name":"Dipyaman Ganguly","author_inst":"CSIR-Indian Institute of Chemical Biology"}],"version":"1","license":"cc_by_nc_nd","type":"PUBLISHAHEADOFPRINT","category":"infectious diseases"},{"rel_doi":"10.1101\/2020.09.22.20199810","rel_title":"Empirical transmission advantage of the D614G mutant strain of SARS-CoV-2","rel_date":"2020-09-23","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.09.22.20199810","rel_abs":"The SARS-CoV-2 lineage carrying the amino acid change D614G has become the dominant variant in the global COVID-19 pandemic. The rapid spread of the G614 mutant suggests that it may have a transmission advantage over the D614 wildtype. Using our previous epidemiological framework to analyze COVID-19 surveillance and sequence data, we estimated that the G614 mutant is 31% (28-34%) more transmissible than the D614 wildtype. As such, interventions that were previously effective in containing or mitigating the D614 wildtype (e.g. in China, Vietnam, Thailand, etc.) might be less effective against the G614 mutant. Our framework can be readily integrated into current COVID-19 surveillance to monitor the emergence and fitness of mutant strains, such that pandemic surveillance, disease control and development of treatment and vaccines can be adjusted dynamically.","rel_num_authors":5,"rel_authors":[{"author_name":"Kathy Leung","author_inst":"The University of Hong Kong"},{"author_name":"Yao Pei","author_inst":"The University of Hong Kong"},{"author_name":"Gabriel M Leung","author_inst":"The University of Hong Kong"},{"author_name":"Tommy T. Y. Lam","author_inst":"The University of Hong Kong"},{"author_name":"Joseph T. Wu","author_inst":"The University of Hong Kong"},{"author_name":"Teresa Arroyo","author_inst":"Hospital Universitario Pr\u00edncipe de Asturias"},{"author_name":"Juan Cuadros","author_inst":"Hospital Universitario Pr\u00edncipe de Asturias"},{"author_name":"Rajsekhar Maiti","author_inst":"ID & BG Hospital"},{"author_name":"Kausik Chaudhuri","author_inst":"ID & BG Hospital"},{"author_name":"Sougata Bagchi","author_inst":"ID & BG Hospital"},{"author_name":"Ayan Maiti","author_inst":"ID & BG Hospital"},{"author_name":"Md. Masoom Parwez","author_inst":"ID & BG Hospital"},{"author_name":"Biswanath Sharma Sarkar","author_inst":"ID & BG Hospital"},{"author_name":"Devlina Roy","author_inst":"ID & BG Hospital"},{"author_name":"Rahul Chakraborty","author_inst":"ID & BG Hospital"},{"author_name":"Janani Srinivasa Vasudevan","author_inst":"CSIR-Institute of Genomics & Integrative Biology"},{"author_name":"Sachin Sharma","author_inst":"CSIR-Institute of Genomics & Integrative Biology"},{"author_name":"Durba Biswas","author_inst":"Medical College Hospital"},{"author_name":"Chikam Maiti","author_inst":"Medical College Hospital"},{"author_name":"Bibhuti Saha","author_inst":"School of Tropical Medicine"},{"author_name":"Prasun Bhattacharya","author_inst":"Medical College Hospital"},{"author_name":"Rajesh Pandey","author_inst":"CSIR-Institute of Genomics & Integrative Biology"},{"author_name":"Shilpak Chatterjee","author_inst":"CSIR-Indian Institute of Chemical Biology"},{"author_name":"Sandip Paul","author_inst":"CSIR-Indian Institute of Chemical Biology"},{"author_name":"Dipyaman Ganguly","author_inst":"CSIR-Indian Institute of Chemical Biology"}],"version":"1","license":"cc_by_nc_nd","type":"PUBLISHAHEADOFPRINT","category":"epidemiology"},{"rel_doi":"10.1101\/2020.09.20.20198283","rel_title":"Exponential distribution of large excess death rates in Europe during the COVID-19 outbreak in the spring of 2020","rel_date":"2020-09-23","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.09.20.20198283","rel_abs":"Excess death rates E during the spring of 2020 are computed in 519 level 3 European territorial units for statistics ---NUTS3 in Belgium (40), France (96), Italy (110), Netherlands (44), Spain (50), Sweden(21) and United Kingdom (179)--- from 2020 provisional week deaths, the population numbers for 2020, and observations in previous years (reference or baseline), all of them obtained from Eurostat web page. Excess death rates are classified in three tiers. Largest 27 excess death rates (tier 1, E>1721x106) were distributed exponentially with empirical complementary cumulative distribution function (empirical survival function) S following S{propto}2-E\/{epsilon} with {epsilon}1=958(52)x10-6. Tier 2 (the next 52 largest excess death rates, E<1142x10-6 also distributed exponentially with {epsilon}2=379.5(89)x10-6. Tier 3 (smallest 460 excess death rates) were distributed normally. The results suggests that when, within some regions, the outbreak is above a threshold, interaction with neighbouring region become less relevant and the outcomes ---excess death rates--- become exponentially distributed as it happens with independent events.","rel_num_authors":1,"rel_authors":[{"author_name":"Jose Maria Martin-Olalla","author_inst":"Universidad de Sevilla"},{"author_name":"Yao Pei","author_inst":"The University of Hong Kong"},{"author_name":"Gabriel M Leung","author_inst":"The University of Hong Kong"},{"author_name":"Tommy T. Y. Lam","author_inst":"The University of Hong Kong"},{"author_name":"Joseph T. Wu","author_inst":"The University of Hong Kong"},{"author_name":"Teresa Arroyo","author_inst":"Hospital Universitario Pr\u00edncipe de Asturias"},{"author_name":"Juan Cuadros","author_inst":"Hospital Universitario Pr\u00edncipe de Asturias"},{"author_name":"Rajsekhar Maiti","author_inst":"ID & BG Hospital"},{"author_name":"Kausik Chaudhuri","author_inst":"ID & BG Hospital"},{"author_name":"Sougata Bagchi","author_inst":"ID & BG Hospital"},{"author_name":"Ayan Maiti","author_inst":"ID & BG Hospital"},{"author_name":"Md. Masoom Parwez","author_inst":"ID & BG Hospital"},{"author_name":"Biswanath Sharma Sarkar","author_inst":"ID & BG Hospital"},{"author_name":"Devlina Roy","author_inst":"ID & BG Hospital"},{"author_name":"Rahul Chakraborty","author_inst":"ID & BG Hospital"},{"author_name":"Janani Srinivasa Vasudevan","author_inst":"CSIR-Institute of Genomics & Integrative Biology"},{"author_name":"Sachin Sharma","author_inst":"CSIR-Institute of Genomics & Integrative Biology"},{"author_name":"Durba Biswas","author_inst":"Medical College Hospital"},{"author_name":"Chikam Maiti","author_inst":"Medical College Hospital"},{"author_name":"Bibhuti Saha","author_inst":"School of Tropical Medicine"},{"author_name":"Prasun Bhattacharya","author_inst":"Medical College Hospital"},{"author_name":"Rajesh Pandey","author_inst":"CSIR-Institute of Genomics & Integrative Biology"},{"author_name":"Shilpak Chatterjee","author_inst":"CSIR-Indian Institute of Chemical Biology"},{"author_name":"Sandip Paul","author_inst":"CSIR-Indian Institute of Chemical Biology"},{"author_name":"Dipyaman Ganguly","author_inst":"CSIR-Indian Institute of Chemical Biology"}],"version":"1","license":"cc_by_nc_nd","type":"PUBLISHAHEADOFPRINT","category":"epidemiology"},{"rel_doi":"10.1101\/2020.09.22.20198275","rel_title":"Knowledge, Attitude and Practice towards COVID-19 among people in Bangladesh during the pandemic: a cross-sectional study.","rel_date":"2020-09-23","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.09.22.20198275","rel_abs":"The world is grappling with Covid-19, a dire public health crisis. Preventive and control measures are adopted to reduce the spread of COVID-19. It is important to know the knowledge, attitude, and practice (KAP) of people towards this pandemic to suggest appropriate coping strategies. The aim of this study was to assess the KAP of Bangladeshi people towards Covid-19 and determinants of those KAPs. We conducted a cross-sectional survey of 492 Bangladeshi people aged above 18 years from May 7 to 29, 2020 throughout the country. Simple and multiple logistic regression analyses were conducted to identify the factors associated with KAP on COVID-19. About 45% of respondents had good knowledge, 49% of respondents expressed positive attitude towards controlling of COVID-19 and 24% of respondents had favorable practice towards COVID-19. Almost three fourths of the respondents went outside home during the lockdown period. Furthermore, the study found that good knowledge and attitude were associated with better practice of COVID-19 health measures. An evidence informed and context specific risk communication and community engagement, and a social and behavior change communication strategy against COVID-19 should be developed in Bangladesh, based on the findings of this study, targeting different socio-economic groups.","rel_num_authors":6,"rel_authors":[{"author_name":"Md. Golam Rabbani","author_inst":"Public Health Foundation, Bangladesh"},{"author_name":"Orin Akter","author_inst":"icddr,b"},{"author_name":"Md. Zahid Hasan","author_inst":"icddr,b"},{"author_name":"Nandeeta Samad","author_inst":"North South University, Dhaka, Bangladesh"},{"author_name":"Shehrin Shaila Mahmood","author_inst":"icddr,b"},{"author_name":"Taufique Joarder","author_inst":"Public Health Foundation, Bangladesh; Johns Hopkins Bloomberg School of Public Health"},{"author_name":"Juan Cuadros","author_inst":"Hospital Universitario Pr\u00edncipe de Asturias"},{"author_name":"Rajsekhar Maiti","author_inst":"ID & BG Hospital"},{"author_name":"Kausik Chaudhuri","author_inst":"ID & BG Hospital"},{"author_name":"Sougata Bagchi","author_inst":"ID & BG Hospital"},{"author_name":"Ayan Maiti","author_inst":"ID & BG Hospital"},{"author_name":"Md. Masoom Parwez","author_inst":"ID & BG Hospital"},{"author_name":"Biswanath Sharma Sarkar","author_inst":"ID & BG Hospital"},{"author_name":"Devlina Roy","author_inst":"ID & BG Hospital"},{"author_name":"Rahul Chakraborty","author_inst":"ID & BG Hospital"},{"author_name":"Janani Srinivasa Vasudevan","author_inst":"CSIR-Institute of Genomics & Integrative Biology"},{"author_name":"Sachin Sharma","author_inst":"CSIR-Institute of Genomics & Integrative Biology"},{"author_name":"Durba Biswas","author_inst":"Medical College Hospital"},{"author_name":"Chikam Maiti","author_inst":"Medical College Hospital"},{"author_name":"Bibhuti Saha","author_inst":"School of Tropical Medicine"},{"author_name":"Prasun Bhattacharya","author_inst":"Medical College Hospital"},{"author_name":"Rajesh Pandey","author_inst":"CSIR-Institute of Genomics & Integrative Biology"},{"author_name":"Shilpak Chatterjee","author_inst":"CSIR-Indian Institute of Chemical Biology"},{"author_name":"Sandip Paul","author_inst":"CSIR-Indian Institute of Chemical Biology"},{"author_name":"Dipyaman Ganguly","author_inst":"CSIR-Indian Institute of Chemical Biology"}],"version":"1","license":"cc_no","type":"PUBLISHAHEADOFPRINT","category":"public and global health"},{"rel_doi":"10.1101\/2020.09.22.20199802","rel_title":"Smoking is associated with worse outcomes of COVID-19 particularly among younger adults: A systematic review and meta-analysis","rel_date":"2020-09-23","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.09.22.20199802","rel_abs":"Background: Smoking impairs lung immune functions and damages upper airways, increasing risks of contracting and severity of infectious diseases. Methods: We searched PubMed and Embase for studies published from January 1-May 25, 2020. We included studies reporting smoking behavior of COVID-19 patients and progression of disease, including death. We used a random effects meta-analysis and used meta-regression and lowess regressions to examine relationships in the data. Results: We identified 47 peer-reviewed papers with a total of 31,871 COVID-19 patients, 5,759 (18.1%) experienced disease progression and 5,734 (18.0%) with a history of smoking. Among smokers, 29.2% experienced disease progression, compared with 21.1% of non-smokers. The meta-analysis confirmed an association between smoking and COVID-19 progression (OR 1.56, 95% CI 1.32-1.83, p=0.001). Smoking was associated with increased risk of death from COVID-19 (OR 1.19, 95% CI 1.05-1.34, p=0.007). We found no significant difference (p=0.432) between the effects of smoking on COVID-19 disease progression between adjusted and unadjusted analyses, suggesting that smoking is an independent risk factor for COVID-19 disease progression. We also found the risk of having COVID-19 progression among younger adults (p=0.023), with the effect most pronounced among people under about 45 years old. Conclusions: Smoking is an independent risk for having severe progression of COVID-19, including mortality. The effects seem to be higher among young people. Smoking prevention and cessation should remain a priority for the public, physicians, and public health professionals during the COVID-19 pandemic.","rel_num_authors":2,"rel_authors":[{"author_name":"ROENGRUDEE PATANAVANICH","author_inst":"Faculty of Medicine Ramathibodi Hospital, Mahidol University"},{"author_name":"STANTON A GLANTZ","author_inst":"University of California San Francisco"},{"author_name":"Md. Zahid Hasan","author_inst":"icddr,b"},{"author_name":"Nandeeta Samad","author_inst":"North South University, Dhaka, Bangladesh"},{"author_name":"Shehrin Shaila Mahmood","author_inst":"icddr,b"},{"author_name":"Taufique Joarder","author_inst":"Public Health Foundation, Bangladesh; Johns Hopkins Bloomberg School of Public Health"},{"author_name":"Juan Cuadros","author_inst":"Hospital Universitario Pr\u00edncipe de Asturias"},{"author_name":"Rajsekhar Maiti","author_inst":"ID & BG Hospital"},{"author_name":"Kausik Chaudhuri","author_inst":"ID & BG Hospital"},{"author_name":"Sougata Bagchi","author_inst":"ID & BG Hospital"},{"author_name":"Ayan Maiti","author_inst":"ID & BG Hospital"},{"author_name":"Md. Masoom Parwez","author_inst":"ID & BG Hospital"},{"author_name":"Biswanath Sharma Sarkar","author_inst":"ID & BG Hospital"},{"author_name":"Devlina Roy","author_inst":"ID & BG Hospital"},{"author_name":"Rahul Chakraborty","author_inst":"ID & BG Hospital"},{"author_name":"Janani Srinivasa Vasudevan","author_inst":"CSIR-Institute of Genomics & Integrative Biology"},{"author_name":"Sachin Sharma","author_inst":"CSIR-Institute of Genomics & Integrative Biology"},{"author_name":"Durba Biswas","author_inst":"Medical College Hospital"},{"author_name":"Chikam Maiti","author_inst":"Medical College Hospital"},{"author_name":"Bibhuti Saha","author_inst":"School of Tropical Medicine"},{"author_name":"Prasun Bhattacharya","author_inst":"Medical College Hospital"},{"author_name":"Rajesh Pandey","author_inst":"CSIR-Institute of Genomics & Integrative Biology"},{"author_name":"Shilpak Chatterjee","author_inst":"CSIR-Indian Institute of Chemical Biology"},{"author_name":"Sandip Paul","author_inst":"CSIR-Indian Institute of Chemical Biology"},{"author_name":"Dipyaman Ganguly","author_inst":"CSIR-Indian Institute of Chemical Biology"}],"version":"1","license":"cc_no","type":"PUBLISHAHEADOFPRINT","category":"public and global health"},{"rel_doi":"10.1101\/2020.09.20.20198259","rel_title":"The impact of COVID-19 infection on maternal and reproductive health care services in governmental health institutions of Dessie town, North-East Ethiopia, 2020 G.C.","rel_date":"2020-09-23","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.09.20.20198259","rel_abs":"Background: The COVID 19 pandemic is causing huge stress on the health care system of all countries in the world. The impact of the pandemic is both social and economic. Pregnancy is an exciting and sometimes stressful experience. Being pregnant during a disease outbreak may add extra anxiety and concern for pregnant women and for those who provide care for them [1, 2]. During the initial stages of the pandemic, it appeared Africa would be spared the burden of COVID-19. However, by April 7th, a total of 45 countries within the WHO African region had reported over 7000 cases (although some place it at over 10 000), with at least 292 deaths and 612 people recovered. Ethiopia, being one of the developing countries trying to address the diverse needs of its people, is currently at the verge of the epidemic [5, 7]. Objectives: The general objective of this study was to assess the impact of COVID-19 infection on maternal and reproductive health care services among mothers getting service in governmental health institutions of Dessie town, 2020 G.C. Methods: Institution based cross sectional study design using mixed (quantitative supplemented with qualitative) method was employed to identify the impact of COVID-19 infection on maternal and reproductive health care services among women who get service in governmental health institutions of Dessie town. The study was conducted from July 1-15 \/ 2020. Result: According to this study, Six percent (6%) of antenatal care attendees, 18% of delivery care attendees and nearly half (46.7%) of postnatal care attendees reported inappropriate service delivery due to fear of health care providers, shortage medical supplies and staff work load. The study also showed that utilization of these services was decreased due to fear of clients to go to health institutions. Conclusion and recommendation: This study concluded that COVID-19 significantly affects the quality and utilization of maternal and reproductive health care services. The study also showed that utilization of these services was decreased due to fear of clients to go to health institutions. Ministry of health should continue maternity and reproductive health care services such as family planning to be prioritized as an essential core health service. Key words: COVID-19, impact, antenatal care, Dessie","rel_num_authors":3,"rel_authors":[{"author_name":"Kibir Temesgen Assefa","author_inst":"Wollo University, Ethiopia"},{"author_name":"Amare Workie Gashu","author_inst":"Wollo University"},{"author_name":"Tenagnework Dilnessa Mulualem","author_inst":"Wollo University"},{"author_name":"Nandeeta Samad","author_inst":"North South University, Dhaka, Bangladesh"},{"author_name":"Shehrin Shaila Mahmood","author_inst":"icddr,b"},{"author_name":"Taufique Joarder","author_inst":"Public Health Foundation, Bangladesh; Johns Hopkins Bloomberg School of Public Health"},{"author_name":"Juan Cuadros","author_inst":"Hospital Universitario Pr\u00edncipe de Asturias"},{"author_name":"Rajsekhar Maiti","author_inst":"ID & BG Hospital"},{"author_name":"Kausik Chaudhuri","author_inst":"ID & BG Hospital"},{"author_name":"Sougata Bagchi","author_inst":"ID & BG Hospital"},{"author_name":"Ayan Maiti","author_inst":"ID & BG Hospital"},{"author_name":"Md. Masoom Parwez","author_inst":"ID & BG Hospital"},{"author_name":"Biswanath Sharma Sarkar","author_inst":"ID & BG Hospital"},{"author_name":"Devlina Roy","author_inst":"ID & BG Hospital"},{"author_name":"Rahul Chakraborty","author_inst":"ID & BG Hospital"},{"author_name":"Janani Srinivasa Vasudevan","author_inst":"CSIR-Institute of Genomics & Integrative Biology"},{"author_name":"Sachin Sharma","author_inst":"CSIR-Institute of Genomics & Integrative Biology"},{"author_name":"Durba Biswas","author_inst":"Medical College Hospital"},{"author_name":"Chikam Maiti","author_inst":"Medical College Hospital"},{"author_name":"Bibhuti Saha","author_inst":"School of Tropical Medicine"},{"author_name":"Prasun Bhattacharya","author_inst":"Medical College Hospital"},{"author_name":"Rajesh Pandey","author_inst":"CSIR-Institute of Genomics & Integrative Biology"},{"author_name":"Shilpak Chatterjee","author_inst":"CSIR-Indian Institute of Chemical Biology"},{"author_name":"Sandip Paul","author_inst":"CSIR-Indian Institute of Chemical Biology"},{"author_name":"Dipyaman Ganguly","author_inst":"CSIR-Indian Institute of Chemical Biology"}],"version":"1","license":"cc_no","type":"PUBLISHAHEADOFPRINT","category":"sexual and reproductive health"},{"rel_doi":"10.1101\/2020.09.22.20199125","rel_title":"Molecular Architecture of Early Disseminationand Massive Second Wave of the SARS-CoV-2 Virus in a Major Metropolitan Area","rel_date":"2020-09-23","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.09.22.20199125","rel_abs":"We sequenced the genomes of 5,085 SARS-CoV-2 strains causing two COVID-19 disease waves in metropolitan Houston, Texas, an ethnically diverse region with seven million residents. The genomes were from viruses recovered in the earliest recognized phase of the pandemic in Houston, and an ongoing massive second wave of infections. The virus was originally introduced into Houston many times independently. Virtually all strains in the second wave have a Gly614 amino acid replacement in the spike protein, a polymorphism that has been linked to increased transmission and infectivity. Patients infected with the Gly614 variant strains had significantly higher virus loads in the nasopharynx on initial diagnosis. We found little evidence of a significant relationship between virus genotypes and altered virulence, stressing the linkage between disease severity, underlying medical conditions, and host genetics. Some regions of the spike protein - the primary target of global vaccine efforts - are replete with amino acid replacements, perhaps indicating the action of selection. We exploited the genomic data to generate defined single amino acid replacements in the receptor binding domain of spike protein that, importantly, produced decreased recognition by the neutralizing monoclonal antibody CR30022. Our study is the first analysis of the molecular architecture of SARS-CoV-2 in two infection waves in a major metropolitan region. The findings will help us to understand the origin, composition, and trajectory of future infection waves, and the potential effect of the host immune response and therapeutic maneuvers on SARS-CoV-2 evolution.","rel_num_authors":25,"rel_authors":[{"author_name":"Scott Wesley Long","author_inst":"Houston Methodist Hospital"},{"author_name":"Randall J Olsen","author_inst":"Houston Methodist Hospital"},{"author_name":"Paul A. Christensen","author_inst":"Houston Methodist Hospital"},{"author_name":"David W Bernard","author_inst":"Houston Methodist Hospital"},{"author_name":"James J. Davis","author_inst":"University of Chicago"},{"author_name":"Maulik Shukla","author_inst":"University of Chicago"},{"author_name":"Marcus Nguyen","author_inst":"University of Chicago"},{"author_name":"Matthew Ojeda Saavedra","author_inst":"Houston Methodist Hospital"},{"author_name":"Prasanti Yerramilli","author_inst":"Houston Methodist Hospital"},{"author_name":"Layne Pruitt","author_inst":"Houston Methodist Hospital"},{"author_name":"Sishir Subedi","author_inst":"Houston Methodist Hospital"},{"author_name":"Hung-Che Kuo","author_inst":"The University of Texas at Austin"},{"author_name":"Heather Hendrickson","author_inst":"Houston Methodist Hospital"},{"author_name":"Ghazaleh Eskandari","author_inst":"Houston Methodist Hospital"},{"author_name":"Hoang A.T. Nguyen","author_inst":"Houston Methodist Hospital"},{"author_name":"James Hunter Long","author_inst":"Houston Methodist Hospital"},{"author_name":"Muthiah Kumaraswami","author_inst":"Houston Methodist Hospital"},{"author_name":"Jule Goike","author_inst":"The University of Texas at Austin"},{"author_name":"Daniel Boutz","author_inst":"The University of Texas at Austin"},{"author_name":"Jimmy Gollihar","author_inst":"The University of Texas at Austin"},{"author_name":"Jason S. McLellan","author_inst":"The University of Texas at Austin"},{"author_name":"Chia-Wei Chou","author_inst":"The University of Texas at Austin"},{"author_name":"Kamyab Javanmardi","author_inst":"The University of Texas at Austin"},{"author_name":"Ilya J. Finkelstein","author_inst":"The University of Texas at Austin"},{"author_name":"James Musser","author_inst":"Houston Methodist Hospital"}],"version":"1","license":"cc_by_nc_nd","type":"PUBLISHAHEADOFPRINT","category":"pathology"},{"rel_doi":"10.1101\/2020.09.22.20199703","rel_title":"Prognostic value of sTREM-1 in COVID-19 patients: a biomarker for disease severity and mortality","rel_date":"2020-09-23","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.09.22.20199703","rel_abs":"Background: The uncontrolled inflammatory response plays a critical role in the novel coronavirus disease (COVID-19) and triggering receptor expressed on myeloid cells-1 (TREM-1) is thought to be intricate to inflammatory signal amplification. This study aims to investigate the association between soluble TREM-1 (sTREM-1) and COVID-19 as a prognostic biomarker to predict the disease severity, lethality and clinical management.Methods: We enrolled 91 patients with COVID-19 in domiciliary care (44 patients) or in hospital care (47 patients), who were classified after admission into mild, moderate, severe and critical groups according to their clinical scores. As non-COVID-19 control, 30 healthy volunteers were included. Data on demographic, comorbidities and baseline clinical characteristics were obtained from their medical and nurse records. Peripheral blood samples were collected at admission and after hospitalization outcome to assess cytokine profile and sTREM-1 level by specific immunoassays Results: Within COVID-19 patients, the highest severity was associated with the most significant elevated plasma levels sTREM-1. Using receiver operating curve analysis (ROC), sTREM-1 was found to be predictive of disease severity (AUC= 0.988) and the best cut-off value for predicting in-hospital severity was [&ge;] 116.5 pg\/mL with the sensitivity for 93.3% and specificity for 95.8%. We also described the clinical characteristics of these patients and explored the correlation with markers of the disease aggravation. The levels of sTREM-1 were positively correlated with IL-6, IL-10, blood neutrophils counts, and critical disease scoring (r= 0.68, p<0.0001). On the other hand, sTREM-1 level was significantly negative correlated with lymphocytes counting, and mild disease (r= -0.42, p<0.0001). Higher levels of sTREM-1 were related to poor outcome and death, patients who received dexamethasone tended to have lower sTREM-1 levels. Conclusion: Our results indicated that sTREM-1 in COVID-19 is associated with severe disease development and a prognostic marker for mortality. The use of severity biomarkers such as sTREM-1 together with patients clinical scores could improve the early recognition and monitoring of COVID-19 cases with higher risk of disease worsening. Key words: COVID-19; sTREM-1; Inflammation; Biomarker; Severity; Mortality.","rel_num_authors":46,"rel_authors":[{"author_name":"Pedro V da Silva Neto","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Jonatan C S de Carvalho","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Vinicius E Pimentel","author_inst":"Departamento de Bioquimica e Imunologia. Faculdade de Medicina de Ribeirao Preto  FMRP. Universidade de Sao Paulo USP, Ribeirao Preto, SP, Brazil"},{"author_name":"Malena M Perez","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Ingryd Carmona-Garcia","author_inst":"Escola de Enfermagem de Ribeirao Preto EERP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"},{"author_name":"Nicola T Neto","author_inst":"Escola de Enfermagem de Ribeirao Preto EERP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"},{"author_name":"Diana M Toro","author_inst":"Programa de Pos Graduacao em Imunologia Basica e Aplicada PPGIBA. Instituto de Ciencias Biologicas, Universidade Federal do Amazonas  UFAM, Manaus, AM, Brazil"},{"author_name":"Camilla N S Oliveira","author_inst":"Departamento de Bioquimica e Imunologia. Faculdade de Medicina de Ribeirao Preto  FMRP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil."},{"author_name":"Thais F C Fraga-Silva","author_inst":"Departamento de Bioquimica e Imunologia. Faculdade de Medicina de Ribeirao Preto  FMRP. Universidade de Sao Paulo USP, Ribeirao Preto, SP, Brazil."},{"author_name":"Cristiane M Milanezi","author_inst":"Departamento de Bioquimica e Imunologia. Faculdade de Medicina de Ribeirao Preto  FMRP. Universidade de Sao Paulo USP, Ribeirao Preto, SP, Brazil."},{"author_name":"Lilian C Rodrigues","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Cassia F. S. L. Dias","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Ana C Xavier","author_inst":"Escola de Enfermagem de Ribeirao Preto EERP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"},{"author_name":"Giovanna S Porcel","author_inst":"Escola de Enfermagem de Ribeirao Preto EERP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"},{"author_name":"Isabelle C Guarneri","author_inst":"Escola de Enfermagem de Ribeirao Preto EERP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"},{"author_name":"Kamila Zaparoli","author_inst":"Escola de Enfermagem de Ribeirao Preto EERP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"},{"author_name":"Caroline T Garbato","author_inst":"Escola de Enfermagem de Ribeirao Preto EERP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"},{"author_name":"Jamille G M Argolo","author_inst":"Escola de Enfermagem de Ribeirao Preto EERP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"},{"author_name":"Angelo A F Junior","author_inst":"Escola de Enfermagem de Ribeirao Preto EERP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"},{"author_name":"Alessandro P de Amorim","author_inst":"Hospital Santa Casa de Misericordia de Ribeirao Preto, Ribeirao Preto, SP, Brazil."},{"author_name":"Augusto M Degiovani","author_inst":"Hospital Santa Casa de Misericordia de Ribeirao Preto, Ribeirao Preto, SP, Brazil."},{"author_name":"Dayane P da Silva","author_inst":"Hospital Santa Casa de Misericordia de Ribeirao Preto, Ribeirao Preto, SP, Brazil."},{"author_name":"Debora C Nepomuceno","author_inst":"Hospital Santa Casa de Misericordia de Ribeirao Preto, Ribeirao Preto, SP, Brazil."},{"author_name":"Rafael C da Silva","author_inst":"Hospital Santa Casa de Misericordia de Ribeirao Preto, Ribeirao Preto, SP, Brazil."},{"author_name":"Leticia F Constant","author_inst":"Hospital Santa Casa de Misericordia de Ribeirao Preto, Ribeirao Preto, SP, Brazil."},{"author_name":"Fatima M Ostini","author_inst":"Hospital Santa Casa de Misericordia de Ribeirao Preto, Ribeirao Preto, SP, Brazil."},{"author_name":"Marley R Feitosa","author_inst":"Departamento de Cirurgia e Anatomia, Faculdade de Medicina de Ribeirao Preto  FMRP, Universidade de Sao Paulo (USP), Ribeirao Preto, SP, Brazil"},{"author_name":"Rogerio S Parra","author_inst":"Departamento de Cirurgia e Anatomia, Faculdade de Medicina de Ribeirao Preto  FMRP, Universidade de Sao Paulo (USP), Ribeirao Preto, SP, Brazil"},{"author_name":"Fernando C Vilar","author_inst":"Departamento de Clinica Medica, Faculdade de Medicina de Ribeirao Preto  FMRP, Universidade de Sao Paulo (USP), Ribeirao Preto, SP, Brazil."},{"author_name":"Gilberto G Gaspar","author_inst":"Departamento de Clinica Medica, Faculdade de Medicina de Ribeirao Preto  FMRP, Universidade de Sao Paulo (USP), Ribeirao Preto, SP, Brazil."},{"author_name":"Jose J R da Rocha","author_inst":"Departamento de Cirurgia e Anatomia, Faculdade de Medicina de Ribeirao Preto  FMRP, Universidade de Sao Paulo (USP), Ribeirao Preto, SP, Brazil"},{"author_name":"Omar Feres","author_inst":"Departamento de Cirurgia e Anatomia, Faculdade de Medicina de Ribeirao Preto  FMRP, Universidade de Sao Paulo (USP), Ribeirao Preto, SP, Brazil"},{"author_name":"Rita C C Barbieri","author_inst":"Hospital Sao Paulo, Ribeirao Preto, SP, Brazil."},{"author_name":"Fabiani G Frantz","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Sandra R Maruyama","author_inst":"Departamento de Genetica e Evolucao, Centro de Ciencias Biologicas e da Saude Universidade Federal de Sao Carlos UFSCar, Sao Carlos, SP, Brazil"},{"author_name":"Elisa M S Russo","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Angelina L Viana","author_inst":"Escola de Enfermagem de Ribeirao Preto EERP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"},{"author_name":"Ana P M Fernandes","author_inst":"Escola de Enfermagem de Ribeirao Preto EERP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"},{"author_name":"Isabel K F M Santos","author_inst":"Departamento de Bioquimica e Imunologia. Faculdade de Medicina de Ribeirao Preto  FMRP. Universidade de Sao Paulo USP, Ribeirao Preto, SP, Brazil."},{"author_name":"Vania L D Bonato","author_inst":"Departamento de Bioquimica e Imunologia. Faculdade de Medicina de Ribeirao Preto  FMRP. Universidade de Sao Paulo USP, Ribeirao Preto, SP, Brazil."},{"author_name":"Marcelo Dias-Baruffi","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Adriana Malheiro","author_inst":"Programa de Pos Graduacao em Imunologia Basica e Aplicada  PPGIBA. Instituto de Ciencias Biologicas, Universidade Federal do Amazonas  UFAM, Manaus, AM, Brazil."},{"author_name":"Ruxana T Sadikot","author_inst":"Department of Veterans Affairs, Division of Pulmonary and Critical Care Medicine, Emory University, Atlanta, USA"},{"author_name":"Cristina R B Cardoso","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Lucia H Faccioli","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Carlos A Sorgi","author_inst":"Departamento de Quimica. Faculdade de Filosofia, Ciencias e Letras de Ribeirao Preto  FFCLRP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"}],"version":"1","license":"cc_by_nc_nd","type":"PUBLISHAHEADOFPRINT","category":"infectious diseases"},{"rel_doi":"10.1101\/2020.09.20.20198242","rel_title":"First quarter chronicle of COVID-19: an attempt to measure governments response","rel_date":"2020-09-23","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.09.20.20198242","rel_abs":"The crisis caused by COVID-19 revealed the global unpreparedness for handling the impact of a pandemic. In this paper, we present a first quarter chronicle of COVID- 19 in Hubei China, Italy and Spain, specifically their infection speed, death and fatality rates. By fitting distributions to these rates, we look for the effectiveness of government measures during the pandemic through a number of statistical approaches.","rel_num_authors":8,"rel_authors":[{"author_name":"Sule Sahin","author_inst":"University of Liverpool"},{"author_name":"Maria del Carmen Boado-Penas","author_inst":"University of Liverpool"},{"author_name":"Corina Constantinescu","author_inst":"University of Liverpool"},{"author_name":"Julia Eisenberg","author_inst":"TU Wien"},{"author_name":"Kira Henshaw","author_inst":"University of Liverpool"},{"author_name":"Maoqi Hu","author_inst":"University of Liverpool"},{"author_name":"Jing Wang","author_inst":"University of Liverpool"},{"author_name":"Wei Zhu","author_inst":"University of Liverpool"},{"author_name":"Thais F C Fraga-Silva","author_inst":"Departamento de Bioquimica e Imunologia. Faculdade de Medicina de Ribeirao Preto  FMRP. Universidade de Sao Paulo USP, Ribeirao Preto, SP, Brazil."},{"author_name":"Cristiane M Milanezi","author_inst":"Departamento de Bioquimica e Imunologia. Faculdade de Medicina de Ribeirao Preto  FMRP. Universidade de Sao Paulo USP, Ribeirao Preto, SP, Brazil."},{"author_name":"Lilian C Rodrigues","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Cassia F. S. L. Dias","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Ana C Xavier","author_inst":"Escola de Enfermagem de Ribeirao Preto EERP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"},{"author_name":"Giovanna S Porcel","author_inst":"Escola de Enfermagem de Ribeirao Preto EERP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"},{"author_name":"Isabelle C Guarneri","author_inst":"Escola de Enfermagem de Ribeirao Preto EERP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"},{"author_name":"Kamila Zaparoli","author_inst":"Escola de Enfermagem de Ribeirao Preto EERP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"},{"author_name":"Caroline T Garbato","author_inst":"Escola de Enfermagem de Ribeirao Preto EERP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"},{"author_name":"Jamille G M Argolo","author_inst":"Escola de Enfermagem de Ribeirao Preto EERP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"},{"author_name":"Angelo A F Junior","author_inst":"Escola de Enfermagem de Ribeirao Preto EERP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"},{"author_name":"Alessandro P de Amorim","author_inst":"Hospital Santa Casa de Misericordia de Ribeirao Preto, Ribeirao Preto, SP, Brazil."},{"author_name":"Augusto M Degiovani","author_inst":"Hospital Santa Casa de Misericordia de Ribeirao Preto, Ribeirao Preto, SP, Brazil."},{"author_name":"Dayane P da Silva","author_inst":"Hospital Santa Casa de Misericordia de Ribeirao Preto, Ribeirao Preto, SP, Brazil."},{"author_name":"Debora C Nepomuceno","author_inst":"Hospital Santa Casa de Misericordia de Ribeirao Preto, Ribeirao Preto, SP, Brazil."},{"author_name":"Rafael C da Silva","author_inst":"Hospital Santa Casa de Misericordia de Ribeirao Preto, Ribeirao Preto, SP, Brazil."},{"author_name":"Leticia F Constant","author_inst":"Hospital Santa Casa de Misericordia de Ribeirao Preto, Ribeirao Preto, SP, Brazil."},{"author_name":"Fatima M Ostini","author_inst":"Hospital Santa Casa de Misericordia de Ribeirao Preto, Ribeirao Preto, SP, Brazil."},{"author_name":"Marley R Feitosa","author_inst":"Departamento de Cirurgia e Anatomia, Faculdade de Medicina de Ribeirao Preto  FMRP, Universidade de Sao Paulo (USP), Ribeirao Preto, SP, Brazil"},{"author_name":"Rogerio S Parra","author_inst":"Departamento de Cirurgia e Anatomia, Faculdade de Medicina de Ribeirao Preto  FMRP, Universidade de Sao Paulo (USP), Ribeirao Preto, SP, Brazil"},{"author_name":"Fernando C Vilar","author_inst":"Departamento de Clinica Medica, Faculdade de Medicina de Ribeirao Preto  FMRP, Universidade de Sao Paulo (USP), Ribeirao Preto, SP, Brazil."},{"author_name":"Gilberto G Gaspar","author_inst":"Departamento de Clinica Medica, Faculdade de Medicina de Ribeirao Preto  FMRP, Universidade de Sao Paulo (USP), Ribeirao Preto, SP, Brazil."},{"author_name":"Jose J R da Rocha","author_inst":"Departamento de Cirurgia e Anatomia, Faculdade de Medicina de Ribeirao Preto  FMRP, Universidade de Sao Paulo (USP), Ribeirao Preto, SP, Brazil"},{"author_name":"Omar Feres","author_inst":"Departamento de Cirurgia e Anatomia, Faculdade de Medicina de Ribeirao Preto  FMRP, Universidade de Sao Paulo (USP), Ribeirao Preto, SP, Brazil"},{"author_name":"Rita C C Barbieri","author_inst":"Hospital Sao Paulo, Ribeirao Preto, SP, Brazil."},{"author_name":"Fabiani G Frantz","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Sandra R Maruyama","author_inst":"Departamento de Genetica e Evolucao, Centro de Ciencias Biologicas e da Saude Universidade Federal de Sao Carlos UFSCar, Sao Carlos, SP, Brazil"},{"author_name":"Elisa M S Russo","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Angelina L Viana","author_inst":"Escola de Enfermagem de Ribeirao Preto EERP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"},{"author_name":"Ana P M Fernandes","author_inst":"Escola de Enfermagem de Ribeirao Preto EERP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"},{"author_name":"Isabel K F M Santos","author_inst":"Departamento de Bioquimica e Imunologia. Faculdade de Medicina de Ribeirao Preto  FMRP. Universidade de Sao Paulo USP, Ribeirao Preto, SP, Brazil."},{"author_name":"Vania L D Bonato","author_inst":"Departamento de Bioquimica e Imunologia. Faculdade de Medicina de Ribeirao Preto  FMRP. Universidade de Sao Paulo USP, Ribeirao Preto, SP, Brazil."},{"author_name":"Marcelo Dias-Baruffi","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Adriana Malheiro","author_inst":"Programa de Pos Graduacao em Imunologia Basica e Aplicada  PPGIBA. Instituto de Ciencias Biologicas, Universidade Federal do Amazonas  UFAM, Manaus, AM, Brazil."},{"author_name":"Ruxana T Sadikot","author_inst":"Department of Veterans Affairs, Division of Pulmonary and Critical Care Medicine, Emory University, Atlanta, USA"},{"author_name":"Cristina R B Cardoso","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Lucia H Faccioli","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Carlos A Sorgi","author_inst":"Departamento de Quimica. Faculdade de Filosofia, Ciencias e Letras de Ribeirao Preto  FFCLRP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"}],"version":"1","license":"cc_by_nc_nd","type":"PUBLISHAHEADOFPRINT","category":"health policy"},{"rel_doi":"10.1101\/2020.09.20.20198143","rel_title":"Resuming assisted reproduction services during COVID-19 Pandemic: An Indian experience","rel_date":"2020-09-23","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.09.20.20198143","rel_abs":"Purpose: The pandemic of COVID-19 has affected many countries and medical services including assisted reproductive treatment (ART) have been hampered. The purpose of the study was to assess the preparedness of ART clinics and staff to resume services and patients reasons to initiate treatment and key performance indicators (KPIs) of ART labs during pandemic. Methods: Semi-descriptive report of two private in-vitro fertilization (IVF) clinics in Maharashtra, India, when COVID-19 testing for asymptomatic people was unavailable. Time required for replenishing laboratory supplies, and staff preparedness to function under new norms of pandemic was documented. Infection mitigation measures at workplace and triaging strategy were evaluated. KPIs of the clinics were evaluated. Results: One-third of the patients consulted through telemedicine accepted or were eligible to initiate treatment upon clinic resumption. Lack of safe transport and financial constraints prevented majority from undergoing IVF, and only 9 percent delayed treatment due to fear of pandemic. With adequate training, staff compliance to meet new demands could be achieved within a week, but supply of consumables was a major constraint. 52 cycles of IVF were performed including fresh cycles and frozen embryo transfers with satisfactory KPIs even during pandemic. Conscious sedation and analgesia during oocyte retrieval was associated with reduced procedure time and no intervention for airway maintenance, compared to general anaesthesia. Self reported pain scores by patients ranged from nil to mild on a graphic rating scale. Conclusion: This study provides a practical insight and will aid in forming guidelines for resumption of IVF services during pandemic.","rel_num_authors":8,"rel_authors":[{"author_name":"Padma Rekha Jirge","author_inst":"Sushrut Assisted Conception Clinic & Shreyas Hospital"},{"author_name":"Sadhana Patwardhan","author_inst":"Nagpur Test Tube Baby Centre"},{"author_name":"Dilip Paranjape","author_inst":"Sushrut Assisted Conception Clinic & Shreyas Hospital"},{"author_name":"Shishir Narendra Jirge","author_inst":"Sushrut Assisted Conception Clinic & Shreyas Hospital"},{"author_name":"Deepali Atul Bhomkar","author_inst":"Sushrut Assisted Conception Clinic"},{"author_name":"Shruti Mahesh Chougule","author_inst":"Sushrut Assisted Conception Clinic"},{"author_name":"Anita Salpekar","author_inst":"Nagpur Test Tube Baby Centre"},{"author_name":"Deepak Modi","author_inst":"ICMR-National Institute for Research in Reproductive Heath"},{"author_name":"Thais F C Fraga-Silva","author_inst":"Departamento de Bioquimica e Imunologia. Faculdade de Medicina de Ribeirao Preto  FMRP. Universidade de Sao Paulo USP, Ribeirao Preto, SP, Brazil."},{"author_name":"Cristiane M Milanezi","author_inst":"Departamento de Bioquimica e Imunologia. Faculdade de Medicina de Ribeirao Preto  FMRP. Universidade de Sao Paulo USP, Ribeirao Preto, SP, Brazil."},{"author_name":"Lilian C Rodrigues","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Cassia F. S. L. Dias","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Ana C Xavier","author_inst":"Escola de Enfermagem de Ribeirao Preto EERP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"},{"author_name":"Giovanna S Porcel","author_inst":"Escola de Enfermagem de Ribeirao Preto EERP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"},{"author_name":"Isabelle C Guarneri","author_inst":"Escola de Enfermagem de Ribeirao Preto EERP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"},{"author_name":"Kamila Zaparoli","author_inst":"Escola de Enfermagem de Ribeirao Preto EERP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"},{"author_name":"Caroline T Garbato","author_inst":"Escola de Enfermagem de Ribeirao Preto EERP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"},{"author_name":"Jamille G M Argolo","author_inst":"Escola de Enfermagem de Ribeirao Preto EERP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"},{"author_name":"Angelo A F Junior","author_inst":"Escola de Enfermagem de Ribeirao Preto EERP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"},{"author_name":"Alessandro P de Amorim","author_inst":"Hospital Santa Casa de Misericordia de Ribeirao Preto, Ribeirao Preto, SP, Brazil."},{"author_name":"Augusto M Degiovani","author_inst":"Hospital Santa Casa de Misericordia de Ribeirao Preto, Ribeirao Preto, SP, Brazil."},{"author_name":"Dayane P da Silva","author_inst":"Hospital Santa Casa de Misericordia de Ribeirao Preto, Ribeirao Preto, SP, Brazil."},{"author_name":"Debora C Nepomuceno","author_inst":"Hospital Santa Casa de Misericordia de Ribeirao Preto, Ribeirao Preto, SP, Brazil."},{"author_name":"Rafael C da Silva","author_inst":"Hospital Santa Casa de Misericordia de Ribeirao Preto, Ribeirao Preto, SP, Brazil."},{"author_name":"Leticia F Constant","author_inst":"Hospital Santa Casa de Misericordia de Ribeirao Preto, Ribeirao Preto, SP, Brazil."},{"author_name":"Fatima M Ostini","author_inst":"Hospital Santa Casa de Misericordia de Ribeirao Preto, Ribeirao Preto, SP, Brazil."},{"author_name":"Marley R Feitosa","author_inst":"Departamento de Cirurgia e Anatomia, Faculdade de Medicina de Ribeirao Preto  FMRP, Universidade de Sao Paulo (USP), Ribeirao Preto, SP, Brazil"},{"author_name":"Rogerio S Parra","author_inst":"Departamento de Cirurgia e Anatomia, Faculdade de Medicina de Ribeirao Preto  FMRP, Universidade de Sao Paulo (USP), Ribeirao Preto, SP, Brazil"},{"author_name":"Fernando C Vilar","author_inst":"Departamento de Clinica Medica, Faculdade de Medicina de Ribeirao Preto  FMRP, Universidade de Sao Paulo (USP), Ribeirao Preto, SP, Brazil."},{"author_name":"Gilberto G Gaspar","author_inst":"Departamento de Clinica Medica, Faculdade de Medicina de Ribeirao Preto  FMRP, Universidade de Sao Paulo (USP), Ribeirao Preto, SP, Brazil."},{"author_name":"Jose J R da Rocha","author_inst":"Departamento de Cirurgia e Anatomia, Faculdade de Medicina de Ribeirao Preto  FMRP, Universidade de Sao Paulo (USP), Ribeirao Preto, SP, Brazil"},{"author_name":"Omar Feres","author_inst":"Departamento de Cirurgia e Anatomia, Faculdade de Medicina de Ribeirao Preto  FMRP, Universidade de Sao Paulo (USP), Ribeirao Preto, SP, Brazil"},{"author_name":"Rita C C Barbieri","author_inst":"Hospital Sao Paulo, Ribeirao Preto, SP, Brazil."},{"author_name":"Fabiani G Frantz","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Sandra R Maruyama","author_inst":"Departamento de Genetica e Evolucao, Centro de Ciencias Biologicas e da Saude Universidade Federal de Sao Carlos UFSCar, Sao Carlos, SP, Brazil"},{"author_name":"Elisa M S Russo","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Angelina L Viana","author_inst":"Escola de Enfermagem de Ribeirao Preto EERP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"},{"author_name":"Ana P M Fernandes","author_inst":"Escola de Enfermagem de Ribeirao Preto EERP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"},{"author_name":"Isabel K F M Santos","author_inst":"Departamento de Bioquimica e Imunologia. Faculdade de Medicina de Ribeirao Preto  FMRP. Universidade de Sao Paulo USP, Ribeirao Preto, SP, Brazil."},{"author_name":"Vania L D Bonato","author_inst":"Departamento de Bioquimica e Imunologia. Faculdade de Medicina de Ribeirao Preto  FMRP. Universidade de Sao Paulo USP, Ribeirao Preto, SP, Brazil."},{"author_name":"Marcelo Dias-Baruffi","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Adriana Malheiro","author_inst":"Programa de Pos Graduacao em Imunologia Basica e Aplicada  PPGIBA. Instituto de Ciencias Biologicas, Universidade Federal do Amazonas  UFAM, Manaus, AM, Brazil."},{"author_name":"Ruxana T Sadikot","author_inst":"Department of Veterans Affairs, Division of Pulmonary and Critical Care Medicine, Emory University, Atlanta, USA"},{"author_name":"Cristina R B Cardoso","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Lucia H Faccioli","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Carlos A Sorgi","author_inst":"Departamento de Quimica. Faculdade de Filosofia, Ciencias e Letras de Ribeirao Preto  FFCLRP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"}],"version":"1","license":"cc_by_nc_nd","type":"PUBLISHAHEADOFPRINT","category":"obstetrics and gynecology"},{"rel_doi":"10.1101\/2020.09.22.20199380","rel_title":"Self-applied ELCSA is valid for rapid tracking of household food insecurity among pregnant women during the COVID-19 pandemic","rel_date":"2020-09-23","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.09.22.20199380","rel_abs":"Abstract Background Rapid household food insecurity (HFI) tracking has been identified as a priority in the context of the COVID-19 pandemic and its aftermath. We report the validation of the Latin American and Caribbean Food Security Scale (Escala Latinoamericana y Caribena de Seguridad Alimentaria -ELCSA) among pregnant women in Sri Lanka. Methods The adult eight-items of the English version of ELCSA was translated into Sinhala and Tamil. Cognitive testing (on ten pregnant women and five local experts) and psychometric validation of the self-administered HFI tool was conducted among pregnant women (n=269) attending the Rajarata Pregnancy Cohort (RaPCo) special clinics in Anuradhapura in February 2020. We assessed psychometric properties and fit using a one parameter logistic model (Rasch analysis) using STATA version 14 and WINSTEP software version 4.3.4. Concurrent validity was tested using psychological distress. Results The scale was internally consistent (Cronbachs alpha = 0.79), had a good model fit (Rasch infit statistic range: 0.85 to 1.07). Item 8 (did not eat for the whole day) was removed from the model fit analysis as it was not affirmed by anyone. Item severity scores ranged from -2.15 for not eating a diverse diet to 4.43 for not eating during the whole day. Concurrent validity between HFI and psychological distress was confirmed (r=0.15, p<0.05). Conclusions The self-applied version of ELCSA- pregnancy in Sri Lanka (ELCSA-P-SL) is a valid and feasible tool to track HFI among pregnant women in similar contexts during the COVID-19 pandemic, where social distancing is a major concern and its aftermath.","rel_num_authors":8,"rel_authors":[{"author_name":"Thilini Chanchala Agampodi","author_inst":"Faculty of Medicine and Allied Sciences Rajarata University of Sri Lanka"},{"author_name":"Amber Hromi-Fiedler","author_inst":"Department of social and behavioral sciences, Yale School of Public Health"},{"author_name":"Suneth Buddhika Agampodi","author_inst":"Faculty of Medicine and Allied Sciences, Rajarata University of Sri Lanka"},{"author_name":"Gayani Shashikala Amarasinghe","author_inst":"Faculty of Medicine and Allied Sciences, Rajarata University of Sri Lanka"},{"author_name":"Nuwan Darshana Wickramasinghe","author_inst":"Faculty of Medicine and Allied Sciences, Rajarata University of Sri Lanka"},{"author_name":"Imasha U Jayasinghe","author_inst":"Faculty of Medicine and Allied Sciences, Rajarata University of Sri Lanka"},{"author_name":"Ayesh Umasena Hettiarachchi","author_inst":"Faculty of Medicine and Allied Sciences, Rajarata University of Sri Lanka"},{"author_name":"Rafael Perez-Escamilla","author_inst":"Department of Social and Behavioral Sciences, Yale School of Public Health"},{"author_name":"Thais F C Fraga-Silva","author_inst":"Departamento de Bioquimica e Imunologia. Faculdade de Medicina de Ribeirao Preto  FMRP. Universidade de Sao Paulo USP, Ribeirao Preto, SP, Brazil."},{"author_name":"Cristiane M Milanezi","author_inst":"Departamento de Bioquimica e Imunologia. Faculdade de Medicina de Ribeirao Preto  FMRP. Universidade de Sao Paulo USP, Ribeirao Preto, SP, Brazil."},{"author_name":"Lilian C Rodrigues","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Cassia F. S. L. Dias","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Ana C Xavier","author_inst":"Escola de Enfermagem de Ribeirao Preto EERP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"},{"author_name":"Giovanna S Porcel","author_inst":"Escola de Enfermagem de Ribeirao Preto EERP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"},{"author_name":"Isabelle C Guarneri","author_inst":"Escola de Enfermagem de Ribeirao Preto EERP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"},{"author_name":"Kamila Zaparoli","author_inst":"Escola de Enfermagem de Ribeirao Preto EERP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"},{"author_name":"Caroline T Garbato","author_inst":"Escola de Enfermagem de Ribeirao Preto EERP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"},{"author_name":"Jamille G M Argolo","author_inst":"Escola de Enfermagem de Ribeirao Preto EERP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"},{"author_name":"Angelo A F Junior","author_inst":"Escola de Enfermagem de Ribeirao Preto EERP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"},{"author_name":"Alessandro P de Amorim","author_inst":"Hospital Santa Casa de Misericordia de Ribeirao Preto, Ribeirao Preto, SP, Brazil."},{"author_name":"Augusto M Degiovani","author_inst":"Hospital Santa Casa de Misericordia de Ribeirao Preto, Ribeirao Preto, SP, Brazil."},{"author_name":"Dayane P da Silva","author_inst":"Hospital Santa Casa de Misericordia de Ribeirao Preto, Ribeirao Preto, SP, Brazil."},{"author_name":"Debora C Nepomuceno","author_inst":"Hospital Santa Casa de Misericordia de Ribeirao Preto, Ribeirao Preto, SP, Brazil."},{"author_name":"Rafael C da Silva","author_inst":"Hospital Santa Casa de Misericordia de Ribeirao Preto, Ribeirao Preto, SP, Brazil."},{"author_name":"Leticia F Constant","author_inst":"Hospital Santa Casa de Misericordia de Ribeirao Preto, Ribeirao Preto, SP, Brazil."},{"author_name":"Fatima M Ostini","author_inst":"Hospital Santa Casa de Misericordia de Ribeirao Preto, Ribeirao Preto, SP, Brazil."},{"author_name":"Marley R Feitosa","author_inst":"Departamento de Cirurgia e Anatomia, Faculdade de Medicina de Ribeirao Preto  FMRP, Universidade de Sao Paulo (USP), Ribeirao Preto, SP, Brazil"},{"author_name":"Rogerio S Parra","author_inst":"Departamento de Cirurgia e Anatomia, Faculdade de Medicina de Ribeirao Preto  FMRP, Universidade de Sao Paulo (USP), Ribeirao Preto, SP, Brazil"},{"author_name":"Fernando C Vilar","author_inst":"Departamento de Clinica Medica, Faculdade de Medicina de Ribeirao Preto  FMRP, Universidade de Sao Paulo (USP), Ribeirao Preto, SP, Brazil."},{"author_name":"Gilberto G Gaspar","author_inst":"Departamento de Clinica Medica, Faculdade de Medicina de Ribeirao Preto  FMRP, Universidade de Sao Paulo (USP), Ribeirao Preto, SP, Brazil."},{"author_name":"Jose J R da Rocha","author_inst":"Departamento de Cirurgia e Anatomia, Faculdade de Medicina de Ribeirao Preto  FMRP, Universidade de Sao Paulo (USP), Ribeirao Preto, SP, Brazil"},{"author_name":"Omar Feres","author_inst":"Departamento de Cirurgia e Anatomia, Faculdade de Medicina de Ribeirao Preto  FMRP, Universidade de Sao Paulo (USP), Ribeirao Preto, SP, Brazil"},{"author_name":"Rita C C Barbieri","author_inst":"Hospital Sao Paulo, Ribeirao Preto, SP, Brazil."},{"author_name":"Fabiani G Frantz","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Sandra R Maruyama","author_inst":"Departamento de Genetica e Evolucao, Centro de Ciencias Biologicas e da Saude Universidade Federal de Sao Carlos UFSCar, Sao Carlos, SP, Brazil"},{"author_name":"Elisa M S Russo","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Angelina L Viana","author_inst":"Escola de Enfermagem de Ribeirao Preto EERP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"},{"author_name":"Ana P M Fernandes","author_inst":"Escola de Enfermagem de Ribeirao Preto EERP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"},{"author_name":"Isabel K F M Santos","author_inst":"Departamento de Bioquimica e Imunologia. Faculdade de Medicina de Ribeirao Preto  FMRP. Universidade de Sao Paulo USP, Ribeirao Preto, SP, Brazil."},{"author_name":"Vania L D Bonato","author_inst":"Departamento de Bioquimica e Imunologia. Faculdade de Medicina de Ribeirao Preto  FMRP. Universidade de Sao Paulo USP, Ribeirao Preto, SP, Brazil."},{"author_name":"Marcelo Dias-Baruffi","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Adriana Malheiro","author_inst":"Programa de Pos Graduacao em Imunologia Basica e Aplicada  PPGIBA. Instituto de Ciencias Biologicas, Universidade Federal do Amazonas  UFAM, Manaus, AM, Brazil."},{"author_name":"Ruxana T Sadikot","author_inst":"Department of Veterans Affairs, Division of Pulmonary and Critical Care Medicine, Emory University, Atlanta, USA"},{"author_name":"Cristina R B Cardoso","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Lucia H Faccioli","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Carlos A Sorgi","author_inst":"Departamento de Quimica. Faculdade de Filosofia, Ciencias e Letras de Ribeirao Preto  FFCLRP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"}],"version":"1","license":"cc_by_nc_nd","type":"PUBLISHAHEADOFPRINT","category":"nutrition"},{"rel_doi":"10.1101\/2020.09.18.20197178","rel_title":"Detection of SARS-CoV-2 RNA in fourteen wastewater treatment systems in Uttarakhand and Rajasthan States of North India","rel_date":"2020-09-23","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.09.18.20197178","rel_abs":"We investigated the presence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) RNA at different treatment stages of 15 wastewater treatment plants (WWTPs) in two North Indian states of Rajasthan and Uttarakhand. Untreated (influent), biologically treated, and disinfected wastewater samples were collected from May to August 2020. The qualitative analysis of the wastewater for the presence of SARS-CoV-2 RNA was done using different pre-processing methods. SARS-CoV-2 RNA was detected in 11 out of 39 wastewater samples in Jaipur district and 5 out of 17 wastewater samples in Haridwar District using Reverse-Transcriptase Quantitative Polymerase Chain Reaction (RT-qPCR) for qualitative detection. None of the 56 samples tested for post-secondary or tertiary treatment were found positive for SARS-CoV-2 RNA. The findings indicate that there are no SARS-CoV-2 related risks involved with using the treated effluent for non-potable applications. In contrast, untreated wastewater may be a potential route of viral transmission to the WWTP and sanitation workers. Future studies are imperative to understand the survival rates of these viruses in wastewater.","rel_num_authors":11,"rel_authors":[{"author_name":"Sudipti Arora","author_inst":"Dr. B. Lal Institute of Biotechnology"},{"author_name":"Aditi Nag","author_inst":"Dr. B. Lal Institute of Biotechnology, jaipur"},{"author_name":"Ankur Rajpal","author_inst":"Indian Institute of technology Roorkee"},{"author_name":"Satya Brat Tiwari","author_inst":"Nanyang Environment and Water Research Institute, Interdisciplinary Graduate Programme, Nanyang Technological University, Singapore"},{"author_name":"Jasmine Sethi","author_inst":"Dr. B. Lal Institute of Biotechnology, Jaipur"},{"author_name":"Devanshi Sutaria","author_inst":"Dr. B. Lal Institute of Biotechnology, Jaipur"},{"author_name":"Jayana Rajvanshi","author_inst":"Dr. B. Lal Institute of Biotechnology Jaipur"},{"author_name":"Sonika Saxena","author_inst":"Dr. B. Lal Institute of Biotechnology Jaipur"},{"author_name":"Sandeep Kumar Shrivastava","author_inst":"Dr. B. Lal Clinical Laboratory Jaipur"},{"author_name":"Absar Ahmed Kazmi","author_inst":"Indian Institute of technology Roorkee"},{"author_name":"Vinay Kumar Tyagi","author_inst":"Indian Institute of technology Roorkee"},{"author_name":"Cassia F. S. L. Dias","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Ana C Xavier","author_inst":"Escola de Enfermagem de Ribeirao Preto EERP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"},{"author_name":"Giovanna S Porcel","author_inst":"Escola de Enfermagem de Ribeirao Preto EERP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"},{"author_name":"Isabelle C Guarneri","author_inst":"Escola de Enfermagem de Ribeirao Preto EERP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"},{"author_name":"Kamila Zaparoli","author_inst":"Escola de Enfermagem de Ribeirao Preto EERP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"},{"author_name":"Caroline T Garbato","author_inst":"Escola de Enfermagem de Ribeirao Preto EERP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"},{"author_name":"Jamille G M Argolo","author_inst":"Escola de Enfermagem de Ribeirao Preto EERP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"},{"author_name":"Angelo A F Junior","author_inst":"Escola de Enfermagem de Ribeirao Preto EERP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"},{"author_name":"Alessandro P de Amorim","author_inst":"Hospital Santa Casa de Misericordia de Ribeirao Preto, Ribeirao Preto, SP, Brazil."},{"author_name":"Augusto M Degiovani","author_inst":"Hospital Santa Casa de Misericordia de Ribeirao Preto, Ribeirao Preto, SP, Brazil."},{"author_name":"Dayane P da Silva","author_inst":"Hospital Santa Casa de Misericordia de Ribeirao Preto, Ribeirao Preto, SP, Brazil."},{"author_name":"Debora C Nepomuceno","author_inst":"Hospital Santa Casa de Misericordia de Ribeirao Preto, Ribeirao Preto, SP, Brazil."},{"author_name":"Rafael C da Silva","author_inst":"Hospital Santa Casa de Misericordia de Ribeirao Preto, Ribeirao Preto, SP, Brazil."},{"author_name":"Leticia F Constant","author_inst":"Hospital Santa Casa de Misericordia de Ribeirao Preto, Ribeirao Preto, SP, Brazil."},{"author_name":"Fatima M Ostini","author_inst":"Hospital Santa Casa de Misericordia de Ribeirao Preto, Ribeirao Preto, SP, Brazil."},{"author_name":"Marley R Feitosa","author_inst":"Departamento de Cirurgia e Anatomia, Faculdade de Medicina de Ribeirao Preto  FMRP, Universidade de Sao Paulo (USP), Ribeirao Preto, SP, Brazil"},{"author_name":"Rogerio S Parra","author_inst":"Departamento de Cirurgia e Anatomia, Faculdade de Medicina de Ribeirao Preto  FMRP, Universidade de Sao Paulo (USP), Ribeirao Preto, SP, Brazil"},{"author_name":"Fernando C Vilar","author_inst":"Departamento de Clinica Medica, Faculdade de Medicina de Ribeirao Preto  FMRP, Universidade de Sao Paulo (USP), Ribeirao Preto, SP, Brazil."},{"author_name":"Gilberto G Gaspar","author_inst":"Departamento de Clinica Medica, Faculdade de Medicina de Ribeirao Preto  FMRP, Universidade de Sao Paulo (USP), Ribeirao Preto, SP, Brazil."},{"author_name":"Jose J R da Rocha","author_inst":"Departamento de Cirurgia e Anatomia, Faculdade de Medicina de Ribeirao Preto  FMRP, Universidade de Sao Paulo (USP), Ribeirao Preto, SP, Brazil"},{"author_name":"Omar Feres","author_inst":"Departamento de Cirurgia e Anatomia, Faculdade de Medicina de Ribeirao Preto  FMRP, Universidade de Sao Paulo (USP), Ribeirao Preto, SP, Brazil"},{"author_name":"Rita C C Barbieri","author_inst":"Hospital Sao Paulo, Ribeirao Preto, SP, Brazil."},{"author_name":"Fabiani G Frantz","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Sandra R Maruyama","author_inst":"Departamento de Genetica e Evolucao, Centro de Ciencias Biologicas e da Saude Universidade Federal de Sao Carlos UFSCar, Sao Carlos, SP, Brazil"},{"author_name":"Elisa M S Russo","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Angelina L Viana","author_inst":"Escola de Enfermagem de Ribeirao Preto EERP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"},{"author_name":"Ana P M Fernandes","author_inst":"Escola de Enfermagem de Ribeirao Preto EERP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"},{"author_name":"Isabel K F M Santos","author_inst":"Departamento de Bioquimica e Imunologia. Faculdade de Medicina de Ribeirao Preto  FMRP. Universidade de Sao Paulo USP, Ribeirao Preto, SP, Brazil."},{"author_name":"Vania L D Bonato","author_inst":"Departamento de Bioquimica e Imunologia. Faculdade de Medicina de Ribeirao Preto  FMRP. Universidade de Sao Paulo USP, Ribeirao Preto, SP, Brazil."},{"author_name":"Marcelo Dias-Baruffi","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Adriana Malheiro","author_inst":"Programa de Pos Graduacao em Imunologia Basica e Aplicada  PPGIBA. Instituto de Ciencias Biologicas, Universidade Federal do Amazonas  UFAM, Manaus, AM, Brazil."},{"author_name":"Ruxana T Sadikot","author_inst":"Department of Veterans Affairs, Division of Pulmonary and Critical Care Medicine, Emory University, Atlanta, USA"},{"author_name":"Cristina R B Cardoso","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Lucia H Faccioli","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Carlos A Sorgi","author_inst":"Departamento de Quimica. Faculdade de Filosofia, Ciencias e Letras de Ribeirao Preto  FFCLRP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"}],"version":"1","license":"cc_by_nc","type":"PUBLISHAHEADOFPRINT","category":"epidemiology"},{"rel_doi":"10.1101\/2020.09.22.20198754","rel_title":"Ethnic differences in COVID-19 infection, hospitalisation, and mortality: an OpenSAFELY analysis of 17 million adults in England","rel_date":"2020-09-23","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.09.22.20198754","rel_abs":"Background: COVID-19 has had a disproportionate impact on ethnic minority populations, both in the UK and internationally. To date, much of the evidence has been derived from studies within single healthcare settings, mainly those hospitalised with COVID-19. Working on behalf of NHS England, the aim of this study was to identify ethnic differences in the risk of COVID-19 infection, hospitalisation and mortality using a large general population cohort in England. Methods: We conducted an observational cohort study using linked primary care records of 17.5 million adults between 1 February 2020 and 3 August 2020. Exposure was self-reported ethnicity collapsed into the 5 and 16 ethnicity categories of the English Census. Multivariable Cox proportional hazards regression was used to identify ethnic differences in the risk of being tested and testing positive for SARS-CoV-2 infection, COVID-19 related intensive care unit (ICU) admission, and COVID-19 mortality, adjusted for socio-demographic factors, clinical co-morbidities, geographic region, care home residency, and household size. Results: A total of 17,510,002 adults were included in the study; 63% white (n=11,030,673), 6% south Asian (n=1,034,337), 2% black (n=344,889), 2% other (n=324,730), 1% mixed (n=172,551), and 26% unknown (n=4,602,822). After adjusting for measured explanatory factors, south Asian, black, and mixed groups were marginally more likely to be tested (south Asian HR 1.08, 95%CI 1.07-1.09; black HR 1.08; 95%CI 1.06-1.09, mixed HR 1.03, 95%CI 1.01-1.05), and substantially more likely to test positive for SARS-CoV-2 compared with white adults (south Asian HR 2.02. 95% CI 1.97-2.07; black HR 1.68, 95%CI 1.61-1.76; mixed HR 1.46, 95%CI 1.36-1.56). The risk of being admitted to ICU for COVID-19 was substantially increased in all ethnic minority groups compared with white adults (south Asian HR 2.22, 95%CI 1.96-2.52; black HR 3.07, 95%CI 2.61-3.61; mixed HR 2.86, 95%CI 2.19-3.75, other HR 2.86, 95%CI 2.31-3.63). Risk of COVID-19 mortality was increased by 25-56% in ethnic minority groups compared with white adults (south Asian HR 1.27, 95%CI 1.17-1.38; black HR 1.55, 95%CI 1.38-1.75; mixed HR 1.40, 95%CI 1.12-1.76; other HR 1.25, 95%CI 1.05-1.49). We observed heterogeneity of associations after disaggregation into detailed ethnic groupings; Indian and African groups were at higher risk of all outcomes; Pakistani, Bangladeshi and Caribbean groups were less or equally likely to be tested for SARS-CoV-2, but at higher risk of all other outcomes, Chinese groups were less likely to be tested for and test positive for SARS-CoV-2, more likely to be admitted to ICU, and equally likely to die from COVID-19. Conclusions: We found evidence of substantial ethnic inequalities in the risk of testing positive for SARS-CoV-2, ICU admission, and mortality, which persisted after accounting for explanatory factors, including household size. It is likely that some of this excess risk is related to factors not captured in clinical records such as occupation, experiences of structural discrimination, or inequitable access to health and social services. Prioritizing linkage between health, social care, and employment data and engaging with ethnic minority communities to better understand their lived experiences is essential for generating evidence to prevent further widening of inequalities in a timely and actionable manner.","rel_num_authors":37,"rel_authors":[{"author_name":"Rohini Mathur","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"Christopher T. Rentsch","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"Caroline Morton","author_inst":"University of Oxford"},{"author_name":"William J Hulme","author_inst":"University of Oxford"},{"author_name":"Anna Schultze","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"Brian MacKenna","author_inst":"University of Oxford"},{"author_name":"Rosalind M Eggo","author_inst":"London School of Hygiene & Tropical Medicine"},{"author_name":"Krishnan Bhaskaran","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"Angel YS Wong","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"Elizabeth J Williamson","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"Harriet Forbes","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"Kevin Wing","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"Helen I McDonald","author_inst":"London School of Medicine and Tropical Medicine"},{"author_name":"Chris Bates","author_inst":"The Phoenix Partnership"},{"author_name":"Seb Bacon","author_inst":"University of Oxford"},{"author_name":"Alex J Walker","author_inst":"University of Oxford"},{"author_name":"David Evans","author_inst":"University of Oxford"},{"author_name":"Peter Inglesby","author_inst":"University of Oxford"},{"author_name":"Amir Mehrkar","author_inst":"University of Oxford"},{"author_name":"Helen J Curtis","author_inst":"University of Oxford"},{"author_name":"Nicholas J DeVito","author_inst":"University of Oxford"},{"author_name":"Richard Croker","author_inst":"University of Oxford"},{"author_name":"Henry Drysdale","author_inst":"University of Oxford"},{"author_name":"Jonathan Cockburn","author_inst":"The Phoenix Partnership"},{"author_name":"John Parry","author_inst":"The Phoenix Partnership"},{"author_name":"Frank Hester","author_inst":"The Phoenix Partnership"},{"author_name":"Sam Harper","author_inst":"The Phoenix Partnership"},{"author_name":"Ian J Douglas","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"Laurie Tomlinson","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"Stephen Evans","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"Richard Grieve","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"David Harrison","author_inst":"Intensive Care National Audit and Research Centre"},{"author_name":"Kathy Rowan","author_inst":"Intensive Care National Audit and Research Centre"},{"author_name":"Kamlesh Khunti","author_inst":"University of Leicester"},{"author_name":"Nish Chaturvedi","author_inst":"University College London"},{"author_name":"Liam Smeeth","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"Ben Goldacre","author_inst":"University of Oxford"},{"author_name":"Ana P M Fernandes","author_inst":"Escola de Enfermagem de Ribeirao Preto EERP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"},{"author_name":"Isabel K F M Santos","author_inst":"Departamento de Bioquimica e Imunologia. Faculdade de Medicina de Ribeirao Preto  FMRP. Universidade de Sao Paulo USP, Ribeirao Preto, SP, Brazil."},{"author_name":"Vania L D Bonato","author_inst":"Departamento de Bioquimica e Imunologia. Faculdade de Medicina de Ribeirao Preto  FMRP. Universidade de Sao Paulo USP, Ribeirao Preto, SP, Brazil."},{"author_name":"Marcelo Dias-Baruffi","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Adriana Malheiro","author_inst":"Programa de Pos Graduacao em Imunologia Basica e Aplicada  PPGIBA. Instituto de Ciencias Biologicas, Universidade Federal do Amazonas  UFAM, Manaus, AM, Brazil."},{"author_name":"Ruxana T Sadikot","author_inst":"Department of Veterans Affairs, Division of Pulmonary and Critical Care Medicine, Emory University, Atlanta, USA"},{"author_name":"Cristina R B Cardoso","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Lucia H Faccioli","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Carlos A Sorgi","author_inst":"Departamento de Quimica. Faculdade de Filosofia, Ciencias e Letras de Ribeirao Preto  FFCLRP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"}],"version":"1","license":"cc_by","type":"PUBLISHAHEADOFPRINT","category":"epidemiology"},{"rel_doi":"10.1101\/2020.09.20.20197368","rel_title":"Modelling the risk of SARS-CoV-2 infection through PPE doffing in a hospital environment","rel_date":"2020-09-23","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.09.20.20197368","rel_abs":"Self-contamination during doffing of personal protective equipment (PPE) is a concern for healthcare workers (HCW) following SARS-CoV-2 positive patient care. Staff may subconsciously become contaminated through improper glove removal, so quantifying this risk is critical for safe working procedures. HCW surface contact sequences on a respiratory ward were modelled using a discrete-time Markov chin for: IV-drip care, blood pressure monitoring and doctors' rounds. Accretion of viral RNA on gloves during care was modelled using a stochastic recurrence relation. The HCW then doffed PPE and contaminated themselves in a fraction of cases based on increasing case load. The risk of infection from this exposure was quantified using a dose-response methodology. A parametric study was conducted to analyse the effect of: 1a) increasing patient numbers on the ward, 1b) the proportion of COVID-19 cases, 2) the length of a shift and 3) the probability of touching contaminated PPE. The driving factors for infection risk were surface contamination and number of surface contacts. HCWs on a 100% COVID-19 ward were less than 2-fold more at risk than on a 50% COVID ward (1.6% vs 1%), whilst on a 5% COVID-19 ward, the risk dropped to 0.1% per shift (sd=0.6%). IV-drip care resulted in higher risk than blood pressure monitoring (1.1% vs 1% p<0.0001), whilst doctors' rounds produced a 0.6% risk (sd=0.8%). Recommendations include supervised PPE doffing procedures such as the \"doffing buddy\" scheme, maximising hand hygiene compliance post-doffing and targeted surface cleaning for surfaces away from the patient vicinity.","rel_num_authors":14,"rel_authors":[{"author_name":"Marco-Felipe King","author_inst":"University of Leeds"},{"author_name":"Amanda Marie Wilson","author_inst":"University of Arizona"},{"author_name":"Mark H Weir","author_inst":"The Ohio State University"},{"author_name":"Martin Lopez-Garcia","author_inst":"University of Leeds"},{"author_name":"Jessica Proctor","author_inst":"University of Leeds"},{"author_name":"Waseem Hiwar","author_inst":"University of Leeds"},{"author_name":"Amirul Khan","author_inst":"University of Leeds"},{"author_name":"Louise A Fletcher","author_inst":"University of Leeds"},{"author_name":"P Andrew Sleigh","author_inst":"University of Leeds"},{"author_name":"Ian Clifton","author_inst":"Leeds Cystic Fibrosis Trust Strategic Research Centre"},{"author_name":"Stephanie Jane Dancer","author_inst":"Hairmyres Hospital"},{"author_name":"Mark H. Wilcox","author_inst":"eLeeds Teaching Hospital & University of Leeds"},{"author_name":"Kelly A. Reynolds","author_inst":"University of Arizona"},{"author_name":"Catherine J Noakes","author_inst":"University of Leeds"},{"author_name":"Seb Bacon","author_inst":"University of Oxford"},{"author_name":"Alex J Walker","author_inst":"University of Oxford"},{"author_name":"David Evans","author_inst":"University of Oxford"},{"author_name":"Peter Inglesby","author_inst":"University of Oxford"},{"author_name":"Amir Mehrkar","author_inst":"University of Oxford"},{"author_name":"Helen J Curtis","author_inst":"University of Oxford"},{"author_name":"Nicholas J DeVito","author_inst":"University of Oxford"},{"author_name":"Richard Croker","author_inst":"University of Oxford"},{"author_name":"Henry Drysdale","author_inst":"University of Oxford"},{"author_name":"Jonathan Cockburn","author_inst":"The Phoenix Partnership"},{"author_name":"John Parry","author_inst":"The Phoenix Partnership"},{"author_name":"Frank Hester","author_inst":"The Phoenix Partnership"},{"author_name":"Sam Harper","author_inst":"The Phoenix Partnership"},{"author_name":"Ian J Douglas","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"Laurie Tomlinson","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"Stephen Evans","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"Richard Grieve","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"David Harrison","author_inst":"Intensive Care National Audit and Research Centre"},{"author_name":"Kathy Rowan","author_inst":"Intensive Care National Audit and Research Centre"},{"author_name":"Kamlesh Khunti","author_inst":"University of Leicester"},{"author_name":"Nish Chaturvedi","author_inst":"University College London"},{"author_name":"Liam Smeeth","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"Ben Goldacre","author_inst":"University of Oxford"},{"author_name":"Ana P M Fernandes","author_inst":"Escola de Enfermagem de Ribeirao Preto EERP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"},{"author_name":"Isabel K F M Santos","author_inst":"Departamento de Bioquimica e Imunologia. Faculdade de Medicina de Ribeirao Preto  FMRP. Universidade de Sao Paulo USP, Ribeirao Preto, SP, Brazil."},{"author_name":"Vania L D Bonato","author_inst":"Departamento de Bioquimica e Imunologia. Faculdade de Medicina de Ribeirao Preto  FMRP. Universidade de Sao Paulo USP, Ribeirao Preto, SP, Brazil."},{"author_name":"Marcelo Dias-Baruffi","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Adriana Malheiro","author_inst":"Programa de Pos Graduacao em Imunologia Basica e Aplicada  PPGIBA. Instituto de Ciencias Biologicas, Universidade Federal do Amazonas  UFAM, Manaus, AM, Brazil."},{"author_name":"Ruxana T Sadikot","author_inst":"Department of Veterans Affairs, Division of Pulmonary and Critical Care Medicine, Emory University, Atlanta, USA"},{"author_name":"Cristina R B Cardoso","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Lucia H Faccioli","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Carlos A Sorgi","author_inst":"Departamento de Quimica. Faculdade de Filosofia, Ciencias e Letras de Ribeirao Preto  FFCLRP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"}],"version":"1","license":"cc_by","type":"PUBLISHAHEADOFPRINT","category":"public and global health"},{"rel_doi":"10.1101\/2020.09.11.20193029","rel_title":"Covid-19 Cases in India: A Visual Exploratory Data Analysis Model","rel_date":"2020-09-23","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.09.11.20193029","rel_abs":"Covid-19 outbreak was first reported in Wuhan, China. The deadly virus spread not just the disease, but fear around the globe. On January 2020, WHO declared COVID-19 as a Public Health Emergency of International Concern (PHEIC). First case of Covid-19 in India was reported on January 30, 2020. By the time, India was prepared in fighting against the virus. India has taken various measures to tackle the situation. In this paper, an exploratory data analysis of Covid-19 cases in India is carried out. Data namely number of cases, testing done, Case Fatality ratio, Number of deaths, change in visits stringency index and measures taken by the government is used for modelling and visual exploratory data analysis.","rel_num_authors":2,"rel_authors":[{"author_name":"Jayesh S Jr.","author_inst":"School of Engineering,Cochin University of Science and Technology"},{"author_name":"Shilpa Sreedharan Jr.","author_inst":"Wellness Solutions"},{"author_name":"Mark H Weir","author_inst":"The Ohio State University"},{"author_name":"Martin Lopez-Garcia","author_inst":"University of Leeds"},{"author_name":"Jessica Proctor","author_inst":"University of Leeds"},{"author_name":"Waseem Hiwar","author_inst":"University of Leeds"},{"author_name":"Amirul Khan","author_inst":"University of Leeds"},{"author_name":"Louise A Fletcher","author_inst":"University of Leeds"},{"author_name":"P Andrew Sleigh","author_inst":"University of Leeds"},{"author_name":"Ian Clifton","author_inst":"Leeds Cystic Fibrosis Trust Strategic Research Centre"},{"author_name":"Stephanie Jane Dancer","author_inst":"Hairmyres Hospital"},{"author_name":"Mark H. Wilcox","author_inst":"eLeeds Teaching Hospital & University of Leeds"},{"author_name":"Kelly A. Reynolds","author_inst":"University of Arizona"},{"author_name":"Catherine J Noakes","author_inst":"University of Leeds"},{"author_name":"Seb Bacon","author_inst":"University of Oxford"},{"author_name":"Alex J Walker","author_inst":"University of Oxford"},{"author_name":"David Evans","author_inst":"University of Oxford"},{"author_name":"Peter Inglesby","author_inst":"University of Oxford"},{"author_name":"Amir Mehrkar","author_inst":"University of Oxford"},{"author_name":"Helen J Curtis","author_inst":"University of Oxford"},{"author_name":"Nicholas J DeVito","author_inst":"University of Oxford"},{"author_name":"Richard Croker","author_inst":"University of Oxford"},{"author_name":"Henry Drysdale","author_inst":"University of Oxford"},{"author_name":"Jonathan Cockburn","author_inst":"The Phoenix Partnership"},{"author_name":"John Parry","author_inst":"The Phoenix Partnership"},{"author_name":"Frank Hester","author_inst":"The Phoenix Partnership"},{"author_name":"Sam Harper","author_inst":"The Phoenix Partnership"},{"author_name":"Ian J Douglas","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"Laurie Tomlinson","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"Stephen Evans","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"Richard Grieve","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"David Harrison","author_inst":"Intensive Care National Audit and Research Centre"},{"author_name":"Kathy Rowan","author_inst":"Intensive Care National Audit and Research Centre"},{"author_name":"Kamlesh Khunti","author_inst":"University of Leicester"},{"author_name":"Nish Chaturvedi","author_inst":"University College London"},{"author_name":"Liam Smeeth","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"Ben Goldacre","author_inst":"University of Oxford"},{"author_name":"Ana P M Fernandes","author_inst":"Escola de Enfermagem de Ribeirao Preto EERP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"},{"author_name":"Isabel K F M Santos","author_inst":"Departamento de Bioquimica e Imunologia. Faculdade de Medicina de Ribeirao Preto  FMRP. Universidade de Sao Paulo USP, Ribeirao Preto, SP, Brazil."},{"author_name":"Vania L D Bonato","author_inst":"Departamento de Bioquimica e Imunologia. Faculdade de Medicina de Ribeirao Preto  FMRP. Universidade de Sao Paulo USP, Ribeirao Preto, SP, Brazil."},{"author_name":"Marcelo Dias-Baruffi","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Adriana Malheiro","author_inst":"Programa de Pos Graduacao em Imunologia Basica e Aplicada  PPGIBA. Instituto de Ciencias Biologicas, Universidade Federal do Amazonas  UFAM, Manaus, AM, Brazil."},{"author_name":"Ruxana T Sadikot","author_inst":"Department of Veterans Affairs, Division of Pulmonary and Critical Care Medicine, Emory University, Atlanta, USA"},{"author_name":"Cristina R B Cardoso","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Lucia H Faccioli","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Carlos A Sorgi","author_inst":"Departamento de Quimica. Faculdade de Filosofia, Ciencias e Letras de Ribeirao Preto  FFCLRP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"}],"version":"1","license":"cc_by","type":"PUBLISHAHEADOFPRINT","category":"health informatics"},{"rel_doi":"10.1101\/2020.09.21.20196220","rel_title":"Privacy-Protecting, Reliable Response Data Discovery Using COVID-19 Patient Observations","rel_date":"2020-09-23","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.09.21.20196220","rel_abs":"There is an urgent need to answer questions related to COVID-19's clinical course and associations with underlying conditions and health outcomes. Multi-center data are necessary to generate reliable answers, but centralizing data in a single repository is not always possible. Using a privacy-protecting strategy, we launched a public Questions & Answers web portal (https:\/\/covid19questions.org) with analyses of comorbidities, medications and laboratory tests using data from 202 hospitals (59,074 COVID-19 patients) in the USA and Germany. We find, for example, that 8.6% of hospitalizations in which the patient was not admitted to the ICU resulted in the patient returning to the hospital within seven days from discharge and that, when adjusted for age, mortality for hospitalized patients was not significantly different by gender or ethnicity.","rel_num_authors":18,"rel_authors":[{"author_name":"Jihoon Kim","author_inst":"University of California San Diego"},{"author_name":"Larissa Neumann","author_inst":"Ludwig Maximilian University of Munich"},{"author_name":"Paulina Paul","author_inst":"University of California San Diego"},{"author_name":"Michael Aratow","author_inst":"San Mateo Medical Center"},{"author_name":"Douglas S Bell","author_inst":"University of California Los Angeles"},{"author_name":"Jason N Doctor","author_inst":"University of Southern California"},{"author_name":"Ludwig C Hinske","author_inst":"Ludwig Maximilian University"},{"author_name":"Xiaoqian Jiang","author_inst":"University of Texas Health Science Center at Houston"},{"author_name":"Katherine K Kim","author_inst":"University of California Davis"},{"author_name":"Michael E Matheny","author_inst":"Vanderbilt University"},{"author_name":"Daniella Meeker","author_inst":"University of Southern California"},{"author_name":"Mark J Pletcher","author_inst":"University of California San Francisco"},{"author_name":"Lisa M Schilling","author_inst":"University of Colorado Anschutz Medical Campus"},{"author_name":"Spencer SooHoo","author_inst":"Cedars Sinai Medical Center"},{"author_name":"Hua Xu","author_inst":"University of Texas Health Science Center at Houston"},{"author_name":"Kai Zheng","author_inst":"University of California Irvine"},{"author_name":"Lucila Ohno-Machado","author_inst":"University of California San Diego"},{"author_name":"- R2D2 Consortium","author_inst":""},{"author_name":"Amir Mehrkar","author_inst":"University of Oxford"},{"author_name":"Helen J Curtis","author_inst":"University of Oxford"},{"author_name":"Nicholas J DeVito","author_inst":"University of Oxford"},{"author_name":"Richard Croker","author_inst":"University of Oxford"},{"author_name":"Henry Drysdale","author_inst":"University of Oxford"},{"author_name":"Jonathan Cockburn","author_inst":"The Phoenix Partnership"},{"author_name":"John Parry","author_inst":"The Phoenix Partnership"},{"author_name":"Frank Hester","author_inst":"The Phoenix Partnership"},{"author_name":"Sam Harper","author_inst":"The Phoenix Partnership"},{"author_name":"Ian J Douglas","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"Laurie Tomlinson","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"Stephen Evans","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"Richard Grieve","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"David Harrison","author_inst":"Intensive Care National Audit and Research Centre"},{"author_name":"Kathy Rowan","author_inst":"Intensive Care National Audit and Research Centre"},{"author_name":"Kamlesh Khunti","author_inst":"University of Leicester"},{"author_name":"Nish Chaturvedi","author_inst":"University College London"},{"author_name":"Liam Smeeth","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"Ben Goldacre","author_inst":"University of Oxford"},{"author_name":"Ana P M Fernandes","author_inst":"Escola de Enfermagem de Ribeirao Preto EERP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"},{"author_name":"Isabel K F M Santos","author_inst":"Departamento de Bioquimica e Imunologia. Faculdade de Medicina de Ribeirao Preto  FMRP. Universidade de Sao Paulo USP, Ribeirao Preto, SP, Brazil."},{"author_name":"Vania L D Bonato","author_inst":"Departamento de Bioquimica e Imunologia. Faculdade de Medicina de Ribeirao Preto  FMRP. Universidade de Sao Paulo USP, Ribeirao Preto, SP, Brazil."},{"author_name":"Marcelo Dias-Baruffi","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Adriana Malheiro","author_inst":"Programa de Pos Graduacao em Imunologia Basica e Aplicada  PPGIBA. Instituto de Ciencias Biologicas, Universidade Federal do Amazonas  UFAM, Manaus, AM, Brazil."},{"author_name":"Ruxana T Sadikot","author_inst":"Department of Veterans Affairs, Division of Pulmonary and Critical Care Medicine, Emory University, Atlanta, USA"},{"author_name":"Cristina R B Cardoso","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Lucia H Faccioli","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Carlos A Sorgi","author_inst":"Departamento de Quimica. Faculdade de Filosofia, Ciencias e Letras de Ribeirao Preto  FFCLRP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"}],"version":"1","license":"cc_by_nc_nd","type":"PUBLISHAHEADOFPRINT","category":"health informatics"},{"rel_doi":"10.1101\/2020.09.21.20195537","rel_title":"Downregulation of Defensin genes in SARS-CoV-2 infection","rel_date":"2020-09-23","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.09.21.20195537","rel_abs":"Defensins, crucial components of the innate immune system, play a vital role against infection as part of frontline immunity. Association of SARS-CoV-2 infection with defensins has not been investigated till date. In this study, we have investigated the expression of defensin genes in the buccal cavity during COVID-19 infection. Nasopharyngeal\/Oropharyngeal swab samples collected for screening SARS-CoV-2 infection were analyzed for the expression of major defensin genes by the quantitative real-time reverse transcription polymerase chain reaction, qRT-PCR. 40 SARS-CoV-2 infected positive and 40 negative swab samples were selected for the study. Based on the RT-PCR analysis involving gene specific primer for defensin genes, 10 defensin genes were found to be expressed in the Nasopharyngeal\/Oropharyngeal cavity. Six defensin genes were further found to be significantly downregulated in SARS-CoV-2 infected patients as against the control, negative samples based on differential expression analysis. The genes significantly downregulated were defensin beta 4A, 4B, 106B, 107B, 103A and defensin alpha 1B. Downregulation of several defensin genes suggests that innate immunity provided by defensins is or may be compromised in SARS-CoV-2 infection resulting in progression of the disease caused by the virus. Upregulation of defensin gene expression and use of defensin peptides could be attractive therapeutic interventions.","rel_num_authors":4,"rel_authors":[{"author_name":"Mohammed M Idris","author_inst":"CSIR - Centre for Cellular and Molecular Biology"},{"author_name":"Sarena Banu","author_inst":"CSIR - Centre for Cellular and Molecular Biology"},{"author_name":"Archana B Siva","author_inst":"CSIR - Centre for Cellular and Molecular Biology"},{"author_name":"Ramakrishnan Nagaraj","author_inst":"CSIR-Centre for Cellular and Molecular Biology"},{"author_name":"Douglas S Bell","author_inst":"University of California Los Angeles"},{"author_name":"Jason N Doctor","author_inst":"University of Southern California"},{"author_name":"Ludwig C Hinske","author_inst":"Ludwig Maximilian University"},{"author_name":"Xiaoqian Jiang","author_inst":"University of Texas Health Science Center at Houston"},{"author_name":"Katherine K Kim","author_inst":"University of California Davis"},{"author_name":"Michael E Matheny","author_inst":"Vanderbilt University"},{"author_name":"Daniella Meeker","author_inst":"University of Southern California"},{"author_name":"Mark J Pletcher","author_inst":"University of California San Francisco"},{"author_name":"Lisa M Schilling","author_inst":"University of Colorado Anschutz Medical Campus"},{"author_name":"Spencer SooHoo","author_inst":"Cedars Sinai Medical Center"},{"author_name":"Hua Xu","author_inst":"University of Texas Health Science Center at Houston"},{"author_name":"Kai Zheng","author_inst":"University of California Irvine"},{"author_name":"Lucila Ohno-Machado","author_inst":"University of California San Diego"},{"author_name":"- R2D2 Consortium","author_inst":""},{"author_name":"Amir Mehrkar","author_inst":"University of Oxford"},{"author_name":"Helen J Curtis","author_inst":"University of Oxford"},{"author_name":"Nicholas J DeVito","author_inst":"University of Oxford"},{"author_name":"Richard Croker","author_inst":"University of Oxford"},{"author_name":"Henry Drysdale","author_inst":"University of Oxford"},{"author_name":"Jonathan Cockburn","author_inst":"The Phoenix Partnership"},{"author_name":"John Parry","author_inst":"The Phoenix Partnership"},{"author_name":"Frank Hester","author_inst":"The Phoenix Partnership"},{"author_name":"Sam Harper","author_inst":"The Phoenix Partnership"},{"author_name":"Ian J Douglas","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"Laurie Tomlinson","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"Stephen Evans","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"Richard Grieve","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"David Harrison","author_inst":"Intensive Care National Audit and Research Centre"},{"author_name":"Kathy Rowan","author_inst":"Intensive Care National Audit and Research Centre"},{"author_name":"Kamlesh Khunti","author_inst":"University of Leicester"},{"author_name":"Nish Chaturvedi","author_inst":"University College London"},{"author_name":"Liam Smeeth","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"Ben Goldacre","author_inst":"University of Oxford"},{"author_name":"Ana P M Fernandes","author_inst":"Escola de Enfermagem de Ribeirao Preto EERP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"},{"author_name":"Isabel K F M Santos","author_inst":"Departamento de Bioquimica e Imunologia. Faculdade de Medicina de Ribeirao Preto  FMRP. Universidade de Sao Paulo USP, Ribeirao Preto, SP, Brazil."},{"author_name":"Vania L D Bonato","author_inst":"Departamento de Bioquimica e Imunologia. Faculdade de Medicina de Ribeirao Preto  FMRP. Universidade de Sao Paulo USP, Ribeirao Preto, SP, Brazil."},{"author_name":"Marcelo Dias-Baruffi","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Adriana Malheiro","author_inst":"Programa de Pos Graduacao em Imunologia Basica e Aplicada  PPGIBA. Instituto de Ciencias Biologicas, Universidade Federal do Amazonas  UFAM, Manaus, AM, Brazil."},{"author_name":"Ruxana T Sadikot","author_inst":"Department of Veterans Affairs, Division of Pulmonary and Critical Care Medicine, Emory University, Atlanta, USA"},{"author_name":"Cristina R B Cardoso","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Lucia H Faccioli","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Carlos A Sorgi","author_inst":"Departamento de Quimica. Faculdade de Filosofia, Ciencias e Letras de Ribeirao Preto  FFCLRP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"}],"version":"1","license":"cc_no","type":"PUBLISHAHEADOFPRINT","category":"infectious diseases"},{"rel_doi":"10.1101\/2020.09.21.20194019","rel_title":"Putting (Big) Data in Action: Saving Lives with Countrywide Population Movement Monitoring Using Mobile Devices during the COVID-19 Crisis","rel_date":"2020-09-23","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.09.21.20194019","rel_abs":"Many countries have implemented strict social distancing measures in the hope of reducing transmission of SARS-CoV-2 but the effectiveness of these measures is determined by the willingness of populations to comply with restrictions. Consequently, a system of monitoring population movement using existing data sources can inform those making decisions about policy responses to the COVID-19 pandemic. We describe a collaboration with all 3 major domestic telecommunication companies in Hungary to use aggregated anonymous mobile phone usage data to calculate two indices for assessing the effect of movement restrictions: a \"mobility-index\" and a \"stay-at-home (or resting) index\". The strengths and weaknesses of this approach are compared with the smartphone-based, COVID-19 Community Mobility Reports from Google. Data generated by mobile phones have long been identified as a potential means to analyse mass population movement, but its operationalisation raises several technical questions, such as making sense of Call Detail Records, collation of data from different mobile network providers, and personal data protection concerns. The method described here addresses these issues and offers an effective and inexpensive tool to monitor the impact of social distancing measures, achieving high levels of accuracy and resolution. Especially in populations where uptake of smartphones is modest, this method has certain advantages over app-based solutions, with greater population coverage, but it is not an alternative to smartphone-based solutions used for contact tracing and quarantine monitoring. We believe that this method can easily be adapted by other countries.","rel_num_authors":12,"rel_authors":[{"author_name":"Miklos Karoly Szocska","author_inst":"Semmelweis University, Faculty of Health and Public Administration, Health Services Management Training Centre, Digital Health and Data Utilisation Team"},{"author_name":"Peter Pollner","author_inst":"Semmelweis University, Faculty of Health and Public Administration, Health Services Management Training Centre, Digital Health and Data Utilisation Team"},{"author_name":"Istvan Schiszler","author_inst":"Semmelweis University, Faculty of Health and Public Administration, Health Services Management Training Centre, Digital Health and Data Utilisation Team"},{"author_name":"Tamas Joo","author_inst":"Semmelweis University, Faculty of Health and Public Administration, Health Services Management Training Centre, Digital Health and Data Utilisation Team"},{"author_name":"Tamas Palicz","author_inst":"Semmelweis University, Faculty of Health and Public Administration, Health Services Management Training Centre, Digital Health and Data Utilisation Team"},{"author_name":"Martin McKee","author_inst":"University of London,  London School of Hygiene and Tropical Medicine, Department of Health Services Research and Policy"},{"author_name":"- Magyar Telekom Nyrt.","author_inst":""},{"author_name":"- Telenor Magyarorszag Zrt.","author_inst":""},{"author_name":"Adam Sohonyai","author_inst":"Vodafone Hungary"},{"author_name":"Jozsef Szoke","author_inst":"Vodafone Hungary"},{"author_name":"Adam Toth","author_inst":"Vodafone Hungary"},{"author_name":"Peter Gaal","author_inst":"Semmelweis University, Faculty of Health and Public Administration, Health Services Management Training Centre, Digital Health and Data Utilisation Team"},{"author_name":"Lisa M Schilling","author_inst":"University of Colorado Anschutz Medical Campus"},{"author_name":"Spencer SooHoo","author_inst":"Cedars Sinai Medical Center"},{"author_name":"Hua Xu","author_inst":"University of Texas Health Science Center at Houston"},{"author_name":"Kai Zheng","author_inst":"University of California Irvine"},{"author_name":"Lucila Ohno-Machado","author_inst":"University of California San Diego"},{"author_name":"- R2D2 Consortium","author_inst":""},{"author_name":"Amir Mehrkar","author_inst":"University of Oxford"},{"author_name":"Helen J Curtis","author_inst":"University of Oxford"},{"author_name":"Nicholas J DeVito","author_inst":"University of Oxford"},{"author_name":"Richard Croker","author_inst":"University of Oxford"},{"author_name":"Henry Drysdale","author_inst":"University of Oxford"},{"author_name":"Jonathan Cockburn","author_inst":"The Phoenix Partnership"},{"author_name":"John Parry","author_inst":"The Phoenix Partnership"},{"author_name":"Frank Hester","author_inst":"The Phoenix Partnership"},{"author_name":"Sam Harper","author_inst":"The Phoenix Partnership"},{"author_name":"Ian J Douglas","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"Laurie Tomlinson","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"Stephen Evans","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"Richard Grieve","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"David Harrison","author_inst":"Intensive Care National Audit and Research Centre"},{"author_name":"Kathy Rowan","author_inst":"Intensive Care National Audit and Research Centre"},{"author_name":"Kamlesh Khunti","author_inst":"University of Leicester"},{"author_name":"Nish Chaturvedi","author_inst":"University College London"},{"author_name":"Liam Smeeth","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"Ben Goldacre","author_inst":"University of Oxford"},{"author_name":"Ana P M Fernandes","author_inst":"Escola de Enfermagem de Ribeirao Preto EERP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"},{"author_name":"Isabel K F M Santos","author_inst":"Departamento de Bioquimica e Imunologia. Faculdade de Medicina de Ribeirao Preto  FMRP. Universidade de Sao Paulo USP, Ribeirao Preto, SP, Brazil."},{"author_name":"Vania L D Bonato","author_inst":"Departamento de Bioquimica e Imunologia. Faculdade de Medicina de Ribeirao Preto  FMRP. Universidade de Sao Paulo USP, Ribeirao Preto, SP, Brazil."},{"author_name":"Marcelo Dias-Baruffi","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Adriana Malheiro","author_inst":"Programa de Pos Graduacao em Imunologia Basica e Aplicada  PPGIBA. Instituto de Ciencias Biologicas, Universidade Federal do Amazonas  UFAM, Manaus, AM, Brazil."},{"author_name":"Ruxana T Sadikot","author_inst":"Department of Veterans Affairs, Division of Pulmonary and Critical Care Medicine, Emory University, Atlanta, USA"},{"author_name":"Cristina R B Cardoso","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Lucia H Faccioli","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Carlos A Sorgi","author_inst":"Departamento de Quimica. Faculdade de Filosofia, Ciencias e Letras de Ribeirao Preto  FFCLRP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"}],"version":"1","license":"cc_by_nc_nd","type":"PUBLISHAHEADOFPRINT","category":"infectious diseases"},{"rel_doi":"10.1101\/2020.09.21.20196725","rel_title":"An expert judgment model to predict early stages of the COVID-19 outbreak in the United States","rel_date":"2020-09-23","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.09.21.20196725","rel_abs":"During early stages of the COVID-19 pandemic, forecasts provided actionable information about disease transmission to public health decision-makers. Between February and May 2020, experts in infectious disease modeling made weekly predictions about the impact of the pandemic in the U.S. We aggregated these predictions into consensus predictions. In March and April 2020, experts predicted that the number of COVID-19 related deaths in the U.S. by the end of 2020 would be in the range of 150,000 to 250,000, with scenarios of near 1m deaths considered plausible. The wide range of possible future outcomes underscored the uncertainty surrounding the outbreak's trajectory. Experts' predictions of measurable short-term outcomes had varying levels of accuracy over the surveys but showed appropriate levels of uncertainty when aggregated. An expert consensus model can provide important insight early on in an emerging global catastrophe.","rel_num_authors":2,"rel_authors":[{"author_name":"Thomas Charles McAndrew","author_inst":"University of Massachusetts at Amherst"},{"author_name":"Nicholas G Reich","author_inst":"University of Massachusetts at Amherst"},{"author_name":"Istvan Schiszler","author_inst":"Semmelweis University, Faculty of Health and Public Administration, Health Services Management Training Centre, Digital Health and Data Utilisation Team"},{"author_name":"Tamas Joo","author_inst":"Semmelweis University, Faculty of Health and Public Administration, Health Services Management Training Centre, Digital Health and Data Utilisation Team"},{"author_name":"Tamas Palicz","author_inst":"Semmelweis University, Faculty of Health and Public Administration, Health Services Management Training Centre, Digital Health and Data Utilisation Team"},{"author_name":"Martin McKee","author_inst":"University of London,  London School of Hygiene and Tropical Medicine, Department of Health Services Research and Policy"},{"author_name":"- Magyar Telekom Nyrt.","author_inst":""},{"author_name":"- Telenor Magyarorszag Zrt.","author_inst":""},{"author_name":"Adam Sohonyai","author_inst":"Vodafone Hungary"},{"author_name":"Jozsef Szoke","author_inst":"Vodafone Hungary"},{"author_name":"Adam Toth","author_inst":"Vodafone Hungary"},{"author_name":"Peter Gaal","author_inst":"Semmelweis University, Faculty of Health and Public Administration, Health Services Management Training Centre, Digital Health and Data Utilisation Team"},{"author_name":"Lisa M Schilling","author_inst":"University of Colorado Anschutz Medical Campus"},{"author_name":"Spencer SooHoo","author_inst":"Cedars Sinai Medical Center"},{"author_name":"Hua Xu","author_inst":"University of Texas Health Science Center at Houston"},{"author_name":"Kai Zheng","author_inst":"University of California Irvine"},{"author_name":"Lucila Ohno-Machado","author_inst":"University of California San Diego"},{"author_name":"- R2D2 Consortium","author_inst":""},{"author_name":"Amir Mehrkar","author_inst":"University of Oxford"},{"author_name":"Helen J Curtis","author_inst":"University of Oxford"},{"author_name":"Nicholas J DeVito","author_inst":"University of Oxford"},{"author_name":"Richard Croker","author_inst":"University of Oxford"},{"author_name":"Henry Drysdale","author_inst":"University of Oxford"},{"author_name":"Jonathan Cockburn","author_inst":"The Phoenix Partnership"},{"author_name":"John Parry","author_inst":"The Phoenix Partnership"},{"author_name":"Frank Hester","author_inst":"The Phoenix Partnership"},{"author_name":"Sam Harper","author_inst":"The Phoenix Partnership"},{"author_name":"Ian J Douglas","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"Laurie Tomlinson","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"Stephen Evans","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"Richard Grieve","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"David Harrison","author_inst":"Intensive Care National Audit and Research Centre"},{"author_name":"Kathy Rowan","author_inst":"Intensive Care National Audit and Research Centre"},{"author_name":"Kamlesh Khunti","author_inst":"University of Leicester"},{"author_name":"Nish Chaturvedi","author_inst":"University College London"},{"author_name":"Liam Smeeth","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"Ben Goldacre","author_inst":"University of Oxford"},{"author_name":"Ana P M Fernandes","author_inst":"Escola de Enfermagem de Ribeirao Preto EERP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"},{"author_name":"Isabel K F M Santos","author_inst":"Departamento de Bioquimica e Imunologia. Faculdade de Medicina de Ribeirao Preto  FMRP. Universidade de Sao Paulo USP, Ribeirao Preto, SP, Brazil."},{"author_name":"Vania L D Bonato","author_inst":"Departamento de Bioquimica e Imunologia. Faculdade de Medicina de Ribeirao Preto  FMRP. Universidade de Sao Paulo USP, Ribeirao Preto, SP, Brazil."},{"author_name":"Marcelo Dias-Baruffi","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Adriana Malheiro","author_inst":"Programa de Pos Graduacao em Imunologia Basica e Aplicada  PPGIBA. Instituto de Ciencias Biologicas, Universidade Federal do Amazonas  UFAM, Manaus, AM, Brazil."},{"author_name":"Ruxana T Sadikot","author_inst":"Department of Veterans Affairs, Division of Pulmonary and Critical Care Medicine, Emory University, Atlanta, USA"},{"author_name":"Cristina R B Cardoso","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Lucia H Faccioli","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Carlos A Sorgi","author_inst":"Departamento de Quimica. Faculdade de Filosofia, Ciencias e Letras de Ribeirao Preto  FFCLRP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"}],"version":"1","license":"cc_by_nc_nd","type":"PUBLISHAHEADOFPRINT","category":"infectious diseases"},{"rel_doi":"10.1101\/2020.09.22.20128140","rel_title":"Subclinical ocular inflammation in persons recovered from ambulatory COVID-19","rel_date":"2020-09-23","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.09.22.20128140","rel_abs":"Coronavirus disease 2019 (COVID-19) is characterized by striking variability in clinical severity, and a hyperinflammatory response in the lung is associated with high mortality. Little is known about the extent and duration of inflammation in persons recovering from COVID-19. Here, we used spectral domain optical coherence tomography (SD-OCT) to detect the presence of inflammatory cells in the vitreous cavity, an immune-privileged microenvironment, in persons recovered from COVID- 19. Our results provide quasi-histologic evidence that neuroinflammation is present in persons who recovered from COVID-19, only one of whom required hospitalization. Our results also suggest that persons who feel that their recovery is incomplete have evidence of subclinical eye inflammation, which may be a marker of residual inflammation elsewhere as well.","rel_num_authors":6,"rel_authors":[{"author_name":"Mathieu F Bakhoum","author_inst":"University of California San Diego"},{"author_name":"Michele Ritter","author_inst":"University of California San Diego"},{"author_name":"Anupam Garg","author_inst":"University of California San Diego"},{"author_name":"Alison X Chan","author_inst":"University of California San Diego"},{"author_name":"Christine Y Bakhoum","author_inst":"University of California San Diego"},{"author_name":"Davey Smith","author_inst":"University of California San Diego"},{"author_name":"- Magyar Telekom Nyrt.","author_inst":""},{"author_name":"- Telenor Magyarorszag Zrt.","author_inst":""},{"author_name":"Adam Sohonyai","author_inst":"Vodafone Hungary"},{"author_name":"Jozsef Szoke","author_inst":"Vodafone Hungary"},{"author_name":"Adam Toth","author_inst":"Vodafone Hungary"},{"author_name":"Peter Gaal","author_inst":"Semmelweis University, Faculty of Health and Public Administration, Health Services Management Training Centre, Digital Health and Data Utilisation Team"},{"author_name":"Lisa M Schilling","author_inst":"University of Colorado Anschutz Medical Campus"},{"author_name":"Spencer SooHoo","author_inst":"Cedars Sinai Medical Center"},{"author_name":"Hua Xu","author_inst":"University of Texas Health Science Center at Houston"},{"author_name":"Kai Zheng","author_inst":"University of California Irvine"},{"author_name":"Lucila Ohno-Machado","author_inst":"University of California San Diego"},{"author_name":"- R2D2 Consortium","author_inst":""},{"author_name":"Amir Mehrkar","author_inst":"University of Oxford"},{"author_name":"Helen J Curtis","author_inst":"University of Oxford"},{"author_name":"Nicholas J DeVito","author_inst":"University of Oxford"},{"author_name":"Richard Croker","author_inst":"University of Oxford"},{"author_name":"Henry Drysdale","author_inst":"University of Oxford"},{"author_name":"Jonathan Cockburn","author_inst":"The Phoenix Partnership"},{"author_name":"John Parry","author_inst":"The Phoenix Partnership"},{"author_name":"Frank Hester","author_inst":"The Phoenix Partnership"},{"author_name":"Sam Harper","author_inst":"The Phoenix Partnership"},{"author_name":"Ian J Douglas","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"Laurie Tomlinson","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"Stephen Evans","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"Richard Grieve","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"David Harrison","author_inst":"Intensive Care National Audit and Research Centre"},{"author_name":"Kathy Rowan","author_inst":"Intensive Care National Audit and Research Centre"},{"author_name":"Kamlesh Khunti","author_inst":"University of Leicester"},{"author_name":"Nish Chaturvedi","author_inst":"University College London"},{"author_name":"Liam Smeeth","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"Ben Goldacre","author_inst":"University of Oxford"},{"author_name":"Ana P M Fernandes","author_inst":"Escola de Enfermagem de Ribeirao Preto EERP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"},{"author_name":"Isabel K F M Santos","author_inst":"Departamento de Bioquimica e Imunologia. Faculdade de Medicina de Ribeirao Preto  FMRP. Universidade de Sao Paulo USP, Ribeirao Preto, SP, Brazil."},{"author_name":"Vania L D Bonato","author_inst":"Departamento de Bioquimica e Imunologia. Faculdade de Medicina de Ribeirao Preto  FMRP. Universidade de Sao Paulo USP, Ribeirao Preto, SP, Brazil."},{"author_name":"Marcelo Dias-Baruffi","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Adriana Malheiro","author_inst":"Programa de Pos Graduacao em Imunologia Basica e Aplicada  PPGIBA. Instituto de Ciencias Biologicas, Universidade Federal do Amazonas  UFAM, Manaus, AM, Brazil."},{"author_name":"Ruxana T Sadikot","author_inst":"Department of Veterans Affairs, Division of Pulmonary and Critical Care Medicine, Emory University, Atlanta, USA"},{"author_name":"Cristina R B Cardoso","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Lucia H Faccioli","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Carlos A Sorgi","author_inst":"Departamento de Quimica. Faculdade de Filosofia, Ciencias e Letras de Ribeirao Preto  FFCLRP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"}],"version":"1","license":"cc_by_nc_nd","type":"PUBLISHAHEADOFPRINT","category":"infectious diseases"},{"rel_doi":"10.1101\/2020.09.21.20191288","rel_title":"Validation and clinical evaluation of a SARS-CoV-2 Surrogate Virus Neutralization Test (sVNT)","rel_date":"2020-09-23","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.09.21.20191288","rel_abs":"To understand SARS-CoV-2 immunity after natural infection or vaccination, functional assays such as virus neutralizing assays are needed. So far, assays to determine SARS-CoV-2 neutralizing antibodies rely on cell-culture based infection assays either using wild type SARS-CoV-2 or pseudotyped viruses. Such assays are labour-intensive, require appropriate biosafety facilities and are difficult to standardize. Recently, a new surrogate virus neutralisation assay (sVNT) was described that uses the principle of an ELISA to measure the neutralization capacity of anti-SARS-CoV-2 antibodies directed against the receptor binding domain. Here, we performed an independent evaluation of the robustness, specificity and sensitivity on an extensive panel of sera from 269 PCR-confirmed COVID-19 cases and 259 unmatched samples collected before 2020 and compared it to cell-based neutralization assays. We found a high specificity of 99.2 (95%CI: 96.9-99.9) and overall sensitivity of 80.3 (95%CI: 74.9-84.8) for the sVNT. Clinical sensitivity increased between early (<14 days post symptom onset or post diagnosis, dpos\/dpd) and late sera (>14 dpos\/dpd) from 75.0 (64.7-83.2) to 83.1 (76.5-88.1). Also, higher severity was associated with an increase in clinical sensitivity. Upon comparison with cell-based neutralisation assays we determined an analytical sensitivity of 74.3 (56.4-86.9) and 98.2 (89.4-99.9) for titres [&ge;]10 to <40 and [&ge;]40 to <160, respectively. Only samples with a titre [&ge;]160 were always positive in the sVNT. In conclusion, the sVNT can be used as an additional assay to determine the immune status of COVID-19 infected of vaccinated individuals but its value needs to be assessed for the specific context of use.","rel_num_authors":11,"rel_authors":[{"author_name":"Benjamin Meyer","author_inst":"University of Geneva"},{"author_name":"Johan Reimerink","author_inst":"RIVM"},{"author_name":"Giulia Torriani","author_inst":"University of Geneva"},{"author_name":"Fion Brouwer","author_inst":"RIVM"},{"author_name":"Gert-Jan Godeke","author_inst":"RIVM"},{"author_name":"Sabine Yerly","author_inst":"University hospitals of Geneva"},{"author_name":"Marieke Hoogerwerf","author_inst":"RIVM"},{"author_name":"Nicolas Vuilleumier","author_inst":"University hospitals of Geneva"},{"author_name":"Laurent Kaiser","author_inst":"University of Geneva Hospitals"},{"author_name":"Isabella Eckerle","author_inst":"University hospitals of Geneva"},{"author_name":"Chantal Reusken","author_inst":"RIVM"},{"author_name":"Peter Gaal","author_inst":"Semmelweis University, Faculty of Health and Public Administration, Health Services Management Training Centre, Digital Health and Data Utilisation Team"},{"author_name":"Lisa M Schilling","author_inst":"University of Colorado Anschutz Medical Campus"},{"author_name":"Spencer SooHoo","author_inst":"Cedars Sinai Medical Center"},{"author_name":"Hua Xu","author_inst":"University of Texas Health Science Center at Houston"},{"author_name":"Kai Zheng","author_inst":"University of California Irvine"},{"author_name":"Lucila Ohno-Machado","author_inst":"University of California San Diego"},{"author_name":"- R2D2 Consortium","author_inst":""},{"author_name":"Amir Mehrkar","author_inst":"University of Oxford"},{"author_name":"Helen J Curtis","author_inst":"University of Oxford"},{"author_name":"Nicholas J DeVito","author_inst":"University of Oxford"},{"author_name":"Richard Croker","author_inst":"University of Oxford"},{"author_name":"Henry Drysdale","author_inst":"University of Oxford"},{"author_name":"Jonathan Cockburn","author_inst":"The Phoenix Partnership"},{"author_name":"John Parry","author_inst":"The Phoenix Partnership"},{"author_name":"Frank Hester","author_inst":"The Phoenix Partnership"},{"author_name":"Sam Harper","author_inst":"The Phoenix Partnership"},{"author_name":"Ian J Douglas","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"Laurie Tomlinson","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"Stephen Evans","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"Richard Grieve","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"David Harrison","author_inst":"Intensive Care National Audit and Research Centre"},{"author_name":"Kathy Rowan","author_inst":"Intensive Care National Audit and Research Centre"},{"author_name":"Kamlesh Khunti","author_inst":"University of Leicester"},{"author_name":"Nish Chaturvedi","author_inst":"University College London"},{"author_name":"Liam Smeeth","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"Ben Goldacre","author_inst":"University of Oxford"},{"author_name":"Ana P M Fernandes","author_inst":"Escola de Enfermagem de Ribeirao Preto EERP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"},{"author_name":"Isabel K F M Santos","author_inst":"Departamento de Bioquimica e Imunologia. Faculdade de Medicina de Ribeirao Preto  FMRP. Universidade de Sao Paulo USP, Ribeirao Preto, SP, Brazil."},{"author_name":"Vania L D Bonato","author_inst":"Departamento de Bioquimica e Imunologia. Faculdade de Medicina de Ribeirao Preto  FMRP. Universidade de Sao Paulo USP, Ribeirao Preto, SP, Brazil."},{"author_name":"Marcelo Dias-Baruffi","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Adriana Malheiro","author_inst":"Programa de Pos Graduacao em Imunologia Basica e Aplicada  PPGIBA. Instituto de Ciencias Biologicas, Universidade Federal do Amazonas  UFAM, Manaus, AM, Brazil."},{"author_name":"Ruxana T Sadikot","author_inst":"Department of Veterans Affairs, Division of Pulmonary and Critical Care Medicine, Emory University, Atlanta, USA"},{"author_name":"Cristina R B Cardoso","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Lucia H Faccioli","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Carlos A Sorgi","author_inst":"Departamento de Quimica. Faculdade de Filosofia, Ciencias e Letras de Ribeirao Preto  FFCLRP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"}],"version":"1","license":"cc_by_nc_nd","type":"PUBLISHAHEADOFPRINT","category":"infectious diseases"},{"rel_doi":"10.1101\/2020.09.18.20185744","rel_title":"Analysis of external quality assessment samples revealed crucial performance differences between commercial RT-PCR assays for SARS-CoV-2 detection when taking extraction methods and real-time-PCR instruments into account","rel_date":"2020-09-23","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.09.18.20185744","rel_abs":"In limelight of the ongoing pandemic SARS-CoV-2 testing is critical for the diagnosis of infected patients, contact-tracing and mitigating the transmission. Diagnostic laboratories are expected to provide appropriate testing with maximum accuracy. Real-time reverse transcriptase PCR (RT-PCR) is the diagnostic standard yet many commercial diagnostic kits have become available. However, only a handful of studies have reviewed their performance in clinical settings. The aim of this study was to compare the performance of the overall analytical matrix including the extraction kit (BD MAX, Promega, Qiagen), the PCR instrument (Agilent Mx3005P, BD MAX, Qiagen Rotor-Gene, Roche Cobas z 480) and the RT-PCR assay (Altona Diagnostics, CerTest Biotec, R-Biopharm AG) using predefined samples from proficiency testing organizers. The greatest difference of the Ct values between the matrices was 9 cycles. One borderline sample could not be detected by 3 out of 12 analytical matrices and yielded a false negative result. We therefore conclude that diagnostic laboratories should take the complete analytical matrix in addition to the performance values published by the manufacturer for a respective RT-PCR kit into account. With limited resources laboratories have to validate a wide range of kits to determine appropriate analytical matrices for detecting SARS-CoV-2 reliably. The interpretation of clinical results has to be adapted accordingly.","rel_num_authors":4,"rel_authors":[{"author_name":"Monika Malecki","author_inst":"Kliniken der Stadt Koeln gGmbH"},{"author_name":"Jessica Luesebrink","author_inst":"Kliniken der Stadt Koeln gGmbH"},{"author_name":"Andreas Wendel","author_inst":"Kliniken der Stadt Koeln gGmbH"},{"author_name":"Frauke Mattner","author_inst":"Kliniken der Stadt Koeln gGmbH"},{"author_name":"Gert-Jan Godeke","author_inst":"RIVM"},{"author_name":"Sabine Yerly","author_inst":"University hospitals of Geneva"},{"author_name":"Marieke Hoogerwerf","author_inst":"RIVM"},{"author_name":"Nicolas Vuilleumier","author_inst":"University hospitals of Geneva"},{"author_name":"Laurent Kaiser","author_inst":"University of Geneva Hospitals"},{"author_name":"Isabella Eckerle","author_inst":"University hospitals of Geneva"},{"author_name":"Chantal Reusken","author_inst":"RIVM"},{"author_name":"Peter Gaal","author_inst":"Semmelweis University, Faculty of Health and Public Administration, Health Services Management Training Centre, Digital Health and Data Utilisation Team"},{"author_name":"Lisa M Schilling","author_inst":"University of Colorado Anschutz Medical Campus"},{"author_name":"Spencer SooHoo","author_inst":"Cedars Sinai Medical Center"},{"author_name":"Hua Xu","author_inst":"University of Texas Health Science Center at Houston"},{"author_name":"Kai Zheng","author_inst":"University of California Irvine"},{"author_name":"Lucila Ohno-Machado","author_inst":"University of California San Diego"},{"author_name":"- R2D2 Consortium","author_inst":""},{"author_name":"Amir Mehrkar","author_inst":"University of Oxford"},{"author_name":"Helen J Curtis","author_inst":"University of Oxford"},{"author_name":"Nicholas J DeVito","author_inst":"University of Oxford"},{"author_name":"Richard Croker","author_inst":"University of Oxford"},{"author_name":"Henry Drysdale","author_inst":"University of Oxford"},{"author_name":"Jonathan Cockburn","author_inst":"The Phoenix Partnership"},{"author_name":"John Parry","author_inst":"The Phoenix Partnership"},{"author_name":"Frank Hester","author_inst":"The Phoenix Partnership"},{"author_name":"Sam Harper","author_inst":"The Phoenix Partnership"},{"author_name":"Ian J Douglas","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"Laurie Tomlinson","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"Stephen Evans","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"Richard Grieve","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"David Harrison","author_inst":"Intensive Care National Audit and Research Centre"},{"author_name":"Kathy Rowan","author_inst":"Intensive Care National Audit and Research Centre"},{"author_name":"Kamlesh Khunti","author_inst":"University of Leicester"},{"author_name":"Nish Chaturvedi","author_inst":"University College London"},{"author_name":"Liam Smeeth","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"Ben Goldacre","author_inst":"University of Oxford"},{"author_name":"Ana P M Fernandes","author_inst":"Escola de Enfermagem de Ribeirao Preto EERP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"},{"author_name":"Isabel K F M Santos","author_inst":"Departamento de Bioquimica e Imunologia. Faculdade de Medicina de Ribeirao Preto  FMRP. Universidade de Sao Paulo USP, Ribeirao Preto, SP, Brazil."},{"author_name":"Vania L D Bonato","author_inst":"Departamento de Bioquimica e Imunologia. Faculdade de Medicina de Ribeirao Preto  FMRP. Universidade de Sao Paulo USP, Ribeirao Preto, SP, Brazil."},{"author_name":"Marcelo Dias-Baruffi","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Adriana Malheiro","author_inst":"Programa de Pos Graduacao em Imunologia Basica e Aplicada  PPGIBA. Instituto de Ciencias Biologicas, Universidade Federal do Amazonas  UFAM, Manaus, AM, Brazil."},{"author_name":"Ruxana T Sadikot","author_inst":"Department of Veterans Affairs, Division of Pulmonary and Critical Care Medicine, Emory University, Atlanta, USA"},{"author_name":"Cristina R B Cardoso","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Lucia H Faccioli","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Carlos A Sorgi","author_inst":"Departamento de Quimica. Faculdade de Filosofia, Ciencias e Letras de Ribeirao Preto  FFCLRP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"}],"version":"1","license":"cc_no","type":"PUBLISHAHEADOFPRINT","category":"infectious diseases"},{"rel_doi":"10.1101\/2020.09.17.20192872","rel_title":"Cold plasma for SARS-CoV-2 Inactivation","rel_date":"2020-09-23","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.09.17.20192872","rel_abs":"SARS-CoV-2 infectious virions are viable on various surfaces (e.g., plastic, metals, cardboard) for several hours. This presents a transmission cycle for the human infection that can be broken by developing new inactivation approaches. We employed an efficient cold atmospheric plasma (CAP) with argon feed gas to inactivate SARS-CoV-2 on various surfaces including plastic, metal, cardboard, basketball composite leather, football leather, and baseball leather. These results demonstrate the great potential of CAP as a safe and effective means to prevent virus transmission and infections.","rel_num_authors":4,"rel_authors":[{"author_name":"Zhitong Chen","author_inst":"University of California, Los Angeles"},{"author_name":"Gustavo Garcia Jr.","author_inst":"University of California, Los Angeles"},{"author_name":"Vaithilingaraja Arumugaswami","author_inst":"University of California, Los Angeles"},{"author_name":"Richard E. Wirz","author_inst":"University of California, Los Angeles"},{"author_name":"Gert-Jan Godeke","author_inst":"RIVM"},{"author_name":"Sabine Yerly","author_inst":"University hospitals of Geneva"},{"author_name":"Marieke Hoogerwerf","author_inst":"RIVM"},{"author_name":"Nicolas Vuilleumier","author_inst":"University hospitals of Geneva"},{"author_name":"Laurent Kaiser","author_inst":"University of Geneva Hospitals"},{"author_name":"Isabella Eckerle","author_inst":"University hospitals of Geneva"},{"author_name":"Chantal Reusken","author_inst":"RIVM"},{"author_name":"Peter Gaal","author_inst":"Semmelweis University, Faculty of Health and Public Administration, Health Services Management Training Centre, Digital Health and Data Utilisation Team"},{"author_name":"Lisa M Schilling","author_inst":"University of Colorado Anschutz Medical Campus"},{"author_name":"Spencer SooHoo","author_inst":"Cedars Sinai Medical Center"},{"author_name":"Hua Xu","author_inst":"University of Texas Health Science Center at Houston"},{"author_name":"Kai Zheng","author_inst":"University of California Irvine"},{"author_name":"Lucila Ohno-Machado","author_inst":"University of California San Diego"},{"author_name":"- R2D2 Consortium","author_inst":""},{"author_name":"Amir Mehrkar","author_inst":"University of Oxford"},{"author_name":"Helen J Curtis","author_inst":"University of Oxford"},{"author_name":"Nicholas J DeVito","author_inst":"University of Oxford"},{"author_name":"Richard Croker","author_inst":"University of Oxford"},{"author_name":"Henry Drysdale","author_inst":"University of Oxford"},{"author_name":"Jonathan Cockburn","author_inst":"The Phoenix Partnership"},{"author_name":"John Parry","author_inst":"The Phoenix Partnership"},{"author_name":"Frank Hester","author_inst":"The Phoenix Partnership"},{"author_name":"Sam Harper","author_inst":"The Phoenix Partnership"},{"author_name":"Ian J Douglas","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"Laurie Tomlinson","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"Stephen Evans","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"Richard Grieve","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"David Harrison","author_inst":"Intensive Care National Audit and Research Centre"},{"author_name":"Kathy Rowan","author_inst":"Intensive Care National Audit and Research Centre"},{"author_name":"Kamlesh Khunti","author_inst":"University of Leicester"},{"author_name":"Nish Chaturvedi","author_inst":"University College London"},{"author_name":"Liam Smeeth","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"Ben Goldacre","author_inst":"University of Oxford"},{"author_name":"Ana P M Fernandes","author_inst":"Escola de Enfermagem de Ribeirao Preto EERP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"},{"author_name":"Isabel K F M Santos","author_inst":"Departamento de Bioquimica e Imunologia. Faculdade de Medicina de Ribeirao Preto  FMRP. Universidade de Sao Paulo USP, Ribeirao Preto, SP, Brazil."},{"author_name":"Vania L D Bonato","author_inst":"Departamento de Bioquimica e Imunologia. Faculdade de Medicina de Ribeirao Preto  FMRP. Universidade de Sao Paulo USP, Ribeirao Preto, SP, Brazil."},{"author_name":"Marcelo Dias-Baruffi","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Adriana Malheiro","author_inst":"Programa de Pos Graduacao em Imunologia Basica e Aplicada  PPGIBA. Instituto de Ciencias Biologicas, Universidade Federal do Amazonas  UFAM, Manaus, AM, Brazil."},{"author_name":"Ruxana T Sadikot","author_inst":"Department of Veterans Affairs, Division of Pulmonary and Critical Care Medicine, Emory University, Atlanta, USA"},{"author_name":"Cristina R B Cardoso","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Lucia H Faccioli","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Carlos A Sorgi","author_inst":"Departamento de Quimica. Faculdade de Filosofia, Ciencias e Letras de Ribeirao Preto  FFCLRP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"}],"version":"1","license":"cc_no","type":"PUBLISHAHEADOFPRINT","category":"infectious diseases"},{"rel_doi":"10.1101\/2020.09.17.20195867","rel_title":"DOSING OF THROMBOPROPHYLAXIS AND MORTALITY IN CRITICALLY ILL COVID-19 PATIENTS","rel_date":"2020-09-23","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.09.17.20195867","rel_abs":"Background: A substantial proportion of critically ill COVID-19 patients develop thromboembolic complications, but it is unclear whether higher doses of thromboprophylaxis are associated with lower mortality rates. The purpose of the study was to evaluate the association of initial dosing strategy of thromboprophylaxis in critically ill COVID-19 patients and the risk of death, thromboembolism, and bleeding. Method: All critically ill COVID-19 patients admitted to two intensive care units in March and April 2020 were eligible. Patients were categorized into three groups according to initial daily dose of thromboprophylaxis: low (2500-4500 IU tinzaparin or 2500-5000 IU dalteparin), medium (>4500 IU but <175 IU\/kilogram, kg, of body weight tinzaparin or >5000 IU but <200 IU\/kg of body weight dalteparin), and high dose ([&ge;] 175 IU\/kg of body weight tinzaparin or [&ge;]200 IU\/kg of body weight dalteparin). Thromboprophylaxis dosage was based on local standardized recommendations, not on degree of critical illness or risk of thrombosis. Cox proportional hazards regression was used to estimate hazard ratios with corresponding 95% confidence intervals of death within 28 days from ICU admission. Multivariable models were adjusted for sex, age, body-mass index, Simplified Acute Physiology Score III, invasive respiratory support, and initial dosing strategy of thromboprophylaxis. Results: A total of 152 patients were included; 67 received low, 48 medium, and 37 high dose thromboprophylaxis. Baseline characteristics did not differ between groups. Mortality was lower in high (13.5%) vs medium (25.0%) and low dose thromboprophylaxis (38.8%) groups, p{equiv}0.02. The hazard ratio of death was 0.33 (95% confidence intervals 0.13 - 0.87) among those who received high dose, respectively 0.88 (95% confidence intervals 0.43 - 1.83) among those who received medium dose, as compared with those who received low dose thromboprophylaxis. There were fewer thromboembolic events in the high (2.7%) vs medium (18.8%) and low dose thromboprophylaxis (17.9%) groups, p{equiv}0.04, but no difference in the proportion of bleeding events, p{equiv}0.16. Conclusions: Among critically ill COVID-19 patients with respiratory failure, high dose thromboprophylaxis was associated with a lower risk of death and a lower cumulative incidence of thromboembolic events compared with lower doses.","rel_num_authors":12,"rel_authors":[{"author_name":"Sandra Jonmarker","author_inst":"Karolinska Institutet"},{"author_name":"Jacob Hollenberg","author_inst":"Karolinska Institutet"},{"author_name":"Martin Dahlberg","author_inst":"Karolinska Institutet"},{"author_name":"Otto Stackelberg","author_inst":"Karolinska Institutet"},{"author_name":"Jacob Litorell","author_inst":"S\u00f6dersjukhuset"},{"author_name":"\u00c5sa Everhov","author_inst":"Karolinska Institutet"},{"author_name":"Hans J\u00e4rnbert-Pettersson","author_inst":"Karolinska Institutet"},{"author_name":"M\u00e5rten S\u00f6derberg","author_inst":"S\u00f6dersjukhuset"},{"author_name":"Jonathan Grip","author_inst":"Karolinska Institutet"},{"author_name":"Anna Schandl","author_inst":"Karolinska Institutet"},{"author_name":"Mattias G\u016bnther","author_inst":"Karolinska Institutet"},{"author_name":"Maria Cronhjort","author_inst":"Karolinska Institutet"},{"author_name":"Lisa M Schilling","author_inst":"University of Colorado Anschutz Medical Campus"},{"author_name":"Spencer SooHoo","author_inst":"Cedars Sinai Medical Center"},{"author_name":"Hua Xu","author_inst":"University of Texas Health Science Center at Houston"},{"author_name":"Kai Zheng","author_inst":"University of California Irvine"},{"author_name":"Lucila Ohno-Machado","author_inst":"University of California San Diego"},{"author_name":"- R2D2 Consortium","author_inst":""},{"author_name":"Amir Mehrkar","author_inst":"University of Oxford"},{"author_name":"Helen J Curtis","author_inst":"University of Oxford"},{"author_name":"Nicholas J DeVito","author_inst":"University of Oxford"},{"author_name":"Richard Croker","author_inst":"University of Oxford"},{"author_name":"Henry Drysdale","author_inst":"University of Oxford"},{"author_name":"Jonathan Cockburn","author_inst":"The Phoenix Partnership"},{"author_name":"John Parry","author_inst":"The Phoenix Partnership"},{"author_name":"Frank Hester","author_inst":"The Phoenix Partnership"},{"author_name":"Sam Harper","author_inst":"The Phoenix Partnership"},{"author_name":"Ian J Douglas","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"Laurie Tomlinson","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"Stephen Evans","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"Richard Grieve","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"David Harrison","author_inst":"Intensive Care National Audit and Research Centre"},{"author_name":"Kathy Rowan","author_inst":"Intensive Care National Audit and Research Centre"},{"author_name":"Kamlesh Khunti","author_inst":"University of Leicester"},{"author_name":"Nish Chaturvedi","author_inst":"University College London"},{"author_name":"Liam Smeeth","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"Ben Goldacre","author_inst":"University of Oxford"},{"author_name":"Ana P M Fernandes","author_inst":"Escola de Enfermagem de Ribeirao Preto EERP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"},{"author_name":"Isabel K F M Santos","author_inst":"Departamento de Bioquimica e Imunologia. Faculdade de Medicina de Ribeirao Preto  FMRP. Universidade de Sao Paulo USP, Ribeirao Preto, SP, Brazil."},{"author_name":"Vania L D Bonato","author_inst":"Departamento de Bioquimica e Imunologia. Faculdade de Medicina de Ribeirao Preto  FMRP. Universidade de Sao Paulo USP, Ribeirao Preto, SP, Brazil."},{"author_name":"Marcelo Dias-Baruffi","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Adriana Malheiro","author_inst":"Programa de Pos Graduacao em Imunologia Basica e Aplicada  PPGIBA. Instituto de Ciencias Biologicas, Universidade Federal do Amazonas  UFAM, Manaus, AM, Brazil."},{"author_name":"Ruxana T Sadikot","author_inst":"Department of Veterans Affairs, Division of Pulmonary and Critical Care Medicine, Emory University, Atlanta, USA"},{"author_name":"Cristina R B Cardoso","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Lucia H Faccioli","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Carlos A Sorgi","author_inst":"Departamento de Quimica. Faculdade de Filosofia, Ciencias e Letras de Ribeirao Preto  FFCLRP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"}],"version":"1","license":"cc_no","type":"PUBLISHAHEADOFPRINT","category":"intensive care and critical care medicine"},{"rel_doi":"10.1101\/2020.09.20.20197608","rel_title":"At home and online during the early months of the COVID-19 pandemic and the relationship to alcohol consumption in a national sample of U.S. adults","rel_date":"2020-09-23","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.09.20.20197608","rel_abs":"Objective: The current study seeks to understand the links between social media use and alcohol consumption during the early months of the COVID-19 pandemic. Method: Data were from the national Understanding American Study, a probability-based Internet panel weighted to represent the U.S. population. Subjects (N=5874; 51% female) were adults, 18 years and older, who completed a March survey (wave 1) and a follow-up survey one month later (wave 3). Analyses assessed the relationship of social media use at wave 1 with wave 3 alcohol use, accounting for wave 1 alcohol use and the socio-demographic characteristics of the sample. We examined the effect of working or studying from home as a moderator. Results: Twitter and Instagram users, but not Facebook users, drank more frequently at wave 3 than non-users. For Instagram users, more frequent alcohol use at wave 3 was at least partially attributed to the frequency of drinking at wave 1. The interaction between Twitter use and working or studying from home was statistically significant. The combination of being on Twitter and working or studying from home was associated with drinking more days a week. Conclusions: Exposure to content about COVID-19 and increased alcohol consumption during the pandemic may contribute to more frequent alcohol use for some social media users, especially those sheltering at home. The study of public health messaging via social media to change alcohol use behaviors during traumatic events is warranted.","rel_num_authors":3,"rel_authors":[{"author_name":"Karen G Chartier","author_inst":"Virginia Commonwealth University"},{"author_name":"Jeanine P.D. Guidry","author_inst":"Virginia Commonwealth University"},{"author_name":"Catherine A. Lee","author_inst":"George Mason University"},{"author_name":"Otto Stackelberg","author_inst":"Karolinska Institutet"},{"author_name":"Jacob Litorell","author_inst":"S\u00f6dersjukhuset"},{"author_name":"\u00c5sa Everhov","author_inst":"Karolinska Institutet"},{"author_name":"Hans J\u00e4rnbert-Pettersson","author_inst":"Karolinska Institutet"},{"author_name":"M\u00e5rten S\u00f6derberg","author_inst":"S\u00f6dersjukhuset"},{"author_name":"Jonathan Grip","author_inst":"Karolinska Institutet"},{"author_name":"Anna Schandl","author_inst":"Karolinska Institutet"},{"author_name":"Mattias G\u016bnther","author_inst":"Karolinska Institutet"},{"author_name":"Maria Cronhjort","author_inst":"Karolinska Institutet"},{"author_name":"Lisa M Schilling","author_inst":"University of Colorado Anschutz Medical Campus"},{"author_name":"Spencer SooHoo","author_inst":"Cedars Sinai Medical Center"},{"author_name":"Hua Xu","author_inst":"University of Texas Health Science Center at Houston"},{"author_name":"Kai Zheng","author_inst":"University of California Irvine"},{"author_name":"Lucila Ohno-Machado","author_inst":"University of California San Diego"},{"author_name":"- R2D2 Consortium","author_inst":""},{"author_name":"Amir Mehrkar","author_inst":"University of Oxford"},{"author_name":"Helen J Curtis","author_inst":"University of Oxford"},{"author_name":"Nicholas J DeVito","author_inst":"University of Oxford"},{"author_name":"Richard Croker","author_inst":"University of Oxford"},{"author_name":"Henry Drysdale","author_inst":"University of Oxford"},{"author_name":"Jonathan Cockburn","author_inst":"The Phoenix Partnership"},{"author_name":"John Parry","author_inst":"The Phoenix Partnership"},{"author_name":"Frank Hester","author_inst":"The Phoenix Partnership"},{"author_name":"Sam Harper","author_inst":"The Phoenix Partnership"},{"author_name":"Ian J Douglas","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"Laurie Tomlinson","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"Stephen Evans","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"Richard Grieve","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"David Harrison","author_inst":"Intensive Care National Audit and Research Centre"},{"author_name":"Kathy Rowan","author_inst":"Intensive Care National Audit and Research Centre"},{"author_name":"Kamlesh Khunti","author_inst":"University of Leicester"},{"author_name":"Nish Chaturvedi","author_inst":"University College London"},{"author_name":"Liam Smeeth","author_inst":"London School of Hygiene and Tropical Medicine"},{"author_name":"Ben Goldacre","author_inst":"University of Oxford"},{"author_name":"Ana P M Fernandes","author_inst":"Escola de Enfermagem de Ribeirao Preto EERP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"},{"author_name":"Isabel K F M Santos","author_inst":"Departamento de Bioquimica e Imunologia. Faculdade de Medicina de Ribeirao Preto  FMRP. Universidade de Sao Paulo USP, Ribeirao Preto, SP, Brazil."},{"author_name":"Vania L D Bonato","author_inst":"Departamento de Bioquimica e Imunologia. Faculdade de Medicina de Ribeirao Preto  FMRP. Universidade de Sao Paulo USP, Ribeirao Preto, SP, Brazil."},{"author_name":"Marcelo Dias-Baruffi","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Adriana Malheiro","author_inst":"Programa de Pos Graduacao em Imunologia Basica e Aplicada  PPGIBA. Instituto de Ciencias Biologicas, Universidade Federal do Amazonas  UFAM, Manaus, AM, Brazil."},{"author_name":"Ruxana T Sadikot","author_inst":"Department of Veterans Affairs, Division of Pulmonary and Critical Care Medicine, Emory University, Atlanta, USA"},{"author_name":"Cristina R B Cardoso","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Lucia H Faccioli","author_inst":"Departamento de Analises Clinicas, Toxicologicas e Bromatologicas. Faculdade de Ciencias Farmaceuticas de Ribeirao Preto FCFRP. Universidade de Sao Paulo  USP, "},{"author_name":"Carlos A Sorgi","author_inst":"Departamento de Quimica. Faculdade de Filosofia, Ciencias e Letras de Ribeirao Preto  FFCLRP. Universidade de Sao Paulo  USP, Ribeirao Preto, SP, Brazil"}],"version":"1","license":"cc_by_nd","type":"PUBLISHAHEADOFPRINT","category":"addiction medicine"}]}



